STOCK TITAN

Axil Brands, Inc. (AXIL) triples profit but leans on one big buyer

(Moderate)
(Neutral)
Form Type
10-K

Rhea-AI Filing Summary

Axil Brands, Inc. (AXIL) reports a strong fiscal year ended May 31, 2026, driven by its hearing enhancement and protection products, which contributed about 96% of revenue. Net revenues rose 17.5% to $30.8 million, while net income more than tripled to $2.7 million as operating income grew to $3.0 million. Adjusted EBITDA increased 66.2% to $4.0 million, lifting adjusted EBITDA margin to 13.1% from 9.3%.

Growth was led by a major shift toward retail and wholesale in the hearing segment, where those channels grew 136.9% to $9.9 million and reached 33.4% of segment sales, while direct-to-consumer hearing revenue fell 4.3%. This mix change compressed gross margin from 71.0% to 69.3%, though absolute gross profit still increased 14.7% to $21.4 million. Hair and skin care revenue declined 21.9% to $1.2 million as AXIL reduced marketing ahead of a planned Reviv3 rebrand in fiscal 2027.

AXIL ended the year debt‑free and later received about $910,000 of tariff refunds, boosting liquidity. As of August 14, 2026, cash and cash equivalents were roughly $7.42 million. Key structural risks include one hearing customer representing 23% of consolidated net revenues and 69% of segment accounts receivable, and high vendor concentration, with a single hearing supplier providing 79% of that segment’s purchases.

Positive

  • Revenue up 17.5% year over year to $30.85 million, driven mainly by big-box retail growth in the hearing segment.
  • Net income more than tripled to $2.70 million, with adjusted EBITDA up 66.2% to $4.04 million and margin improving to 13.1%.
  • Channel diversification: retail and wholesale expanded to 35.1% of consolidated revenue from 20.5%, reducing reliance on direct-to-consumer.
  • Stronger balance sheet: company is debt‑free and subsequently received about $910,000 of tariff refunds, enhancing liquidity.

Negative

  • Customer concentration: one hearing customer accounted for 23% of consolidated net revenues and 69% of segment accounts receivable.
  • Supplier concentration: a single vendor provided 79% of hearing segment purchases; three vendors supplied 91% of hair and skin care purchases.
  • Margin pressure: gross margin declined from 71.0% to 69.3% as lower‑margin wholesale and retail sales grew to 35.1% of revenue.
  • Hair and skin care revenue fell 21.9% to $1.19 million, with the segment swinging to a small non-cash operating loss.
Net revenues $30,847,570 Fiscal year ended May 31, 2026; up 17.5% from $26,257,522 in 2025
Net income $2,699,349 Fiscal year ended May 31, 2026; up from $854,988 in 2025
Adjusted EBITDA $4,039,411 Non-GAAP; fiscal 2026 vs $2,430,333 in 2025; 13.1% of revenue
Gross profit margin 69.3% Fiscal year 2026; down from 71.0% in fiscal 2025
Hearing segment revenue $29,558,574 Fiscal 2026; approximately 96% of consolidated net revenues
Hair and skin care revenue $1,188,996 Fiscal 2026; down 21.9% from $1,522,421 in 2025
Cash and cash equivalents $7,420,000 Approximate balance as of August 14, 2026
Non-affiliate equity market value $20,708,714 Aggregate market value as of November 28, 2025
Adjusted EBITDA financial
"We calculate adjusted EBITDA as EBITDA, further adjusted for stock-based compensation."
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
International Emergency Economic Powers Act regulatory
"refunds of duties previously paid under the International Emergency Economic Powers Act"
A U.S. law that gives the president broad authority to control trade, financial transactions, and assets during a declared national emergency, such as by imposing sanctions, freezing property, or restricting exports and imports. For investors it matters because those powers can suddenly block deals, cut off access to markets or funds, and change the value of companies or securities much like an emergency brake that can stop or reroute economic activity overnight.
Section 301 of the Trade Act of 1974 regulatory
"new tariff rates generally ranging from 10% to 12.5% ... pursuant to Section 301 of the Trade Act of 1974."
Section 301 of the Trade Act of 1974 is a U.S. law that lets the government investigate foreign trade practices and, if it finds those practices harm U.S. commerce, impose measures such as tariffs, import restrictions, or other penalties. Think of it like a referee’s power to penalize another country for breaking trade rules; for investors, those penalties can change costs, disrupt supply chains, alter competitive positions and quickly affect company profits and stock prices.
Enterprise Risk Management financial
"Cybersecurity is an important part of our Enterprise Risk Management (“ERM”) program"
Enterprise Risk Management is a process companies use to identify, assess, and prepare for potential problems that could disrupt their success, like financial losses or reputation damage. It’s like a safety plan that helps a business stay strong and adapt quickly when unexpected challenges come up. This helps the company protect its future and keep running smoothly.
non-GAAP financial
"These non-GAAP financial measures exclude significant expenses and income that are required by GAAP"
Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.
Net revenues $30,847,570 +17.5% vs $26,257,522 in 2025
Net income $2,699,349 Up from $854,988 in 2025 (over 200% increase)
Adjusted EBITDA $4,039,411 +66.2% vs $2,430,333 in 2025
Gross margin 69.3% Down from 71.0% in 2025 (−1.7 percentage points)

FAQ

How did AXIL (Axil Brands, Inc.) perform financially in fiscal year 2026?

AXIL reported net revenues of $30.85 million, up 17.5% from 2025, and net income of $2.70 million, more than tripling year over year. Adjusted EBITDA rose 66.2% to $4.04 million, reflecting stronger scale and expanding retail distribution.

What were AXIL’s main revenue drivers and segment mix in 2026?

The hearing enhancement and protection segment generated $29.56 million, about 96% of revenue, while hair and skin care contributed $1.19 million. Retail and wholesale in hearing grew 136.9% to $9.86 million, offsetting a 4.3% decline in direct‑to‑consumer hearing sales.

How did AXIL’s profitability and margins change in 2026?

Gross profit increased to $21.38 million, but gross margin slipped from 71.0% to 69.3% as wholesale and retail grew to 35.1% of revenue. Adjusted EBITDA margin improved from 9.3% to 13.1%, supported by operating leverage despite lower product margins.

What is AXIL’s liquidity and debt position as of the latest reporting?

AXIL ended fiscal 2026 with no outstanding borrowings and later repaid its remaining disaster loan. As of August 14, 2026, cash and cash equivalents were about $7.42 million, aided by roughly $910,000 in IEEPA tariff refunds received after year‑end.

How concentrated are AXIL’s customers and suppliers?

In 2026, one hearing customer represented 23% of consolidated net revenues and 69% of that segment’s receivables. A single vendor supplied 79% of hearing segment purchases, while three vendors provided 91% of hair and skin care purchases, indicating meaningful concentration risk.

What impact did tariffs and refunds have on AXIL’s results?

AXIL paid about $900,000 in IEEPA duties during 2026 and recorded only refunds actually received in that year. After May 31, 2026, it received approximately $910,000 in refunds including interest, to be recognized in 2027, favorably affecting gross margin but not underlying operations.

What are AXIL’s plans for its hair and skin care business?

Hair and skin care revenue fell 21.9% to $1.19 million as AXIL reduced marketing ahead of a planned Reviv3 brand relaunch in September 2026. The company expects to add distributors and retailers in fiscal 2027, though timing and order volumes remain uncertain.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 2026 FY 0001718500 0001718500 2025-06-01 2026-05-31 0001718500 2025-11-28 0001718500 2026-08-14 0001718500 axil:JeffToghraieMember 2022-05-10 0001718500 axil:JeffToghraieMember 2024-10-14 0001718500 axil:JeffBrownMember 2022-05-10 0001718500 axil:JeffBrownMember 2024-10-14 0001718500 2026-05-31 0001718500 2025-05-31 0001718500 2024-06-01 2025-05-31 0001718500 us-gaap:PreferredStockMember 2025-05-31 0001718500 us-gaap:CommonStockMember 2025-05-31 0001718500 us-gaap:AdditionalPaidInCapitalMember 2025-05-31 0001718500 us-gaap:RetainedEarningsMember 2025-05-31 0001718500 us-gaap:PreferredStockMember 2024-05-31 0001718500 us-gaap:CommonStockMember 2024-05-31 0001718500 us-gaap:AdditionalPaidInCapitalMember 2024-05-31 0001718500 us-gaap:RetainedEarningsMember 2024-05-31 0001718500 2024-05-31 0001718500 us-gaap:PreferredStockMember 2025-06-01 2026-05-31 0001718500 us-gaap:CommonStockMember 2025-06-01 2026-05-31 0001718500 us-gaap:AdditionalPaidInCapitalMember 2025-06-01 2026-05-31 0001718500 us-gaap:RetainedEarningsMember 2025-06-01 2026-05-31 0001718500 us-gaap:PreferredStockMember 2024-06-01 2025-05-31 0001718500 us-gaap:CommonStockMember 2024-06-01 2025-05-31 0001718500 us-gaap:AdditionalPaidInCapitalMember 2024-06-01 2025-05-31 0001718500 us-gaap:RetainedEarningsMember 2024-06-01 2025-05-31 0001718500 us-gaap:PreferredStockMember 2026-05-31 0001718500 us-gaap:CommonStockMember 2026-05-31 0001718500 us-gaap:AdditionalPaidInCapitalMember 2026-05-31 0001718500 us-gaap:RetainedEarningsMember 2026-05-31 0001718500 axil:SellingsAndMarketingExpenseMember 2025-06-01 2026-05-31 0001718500 axil:ProfessionalAndConsultingExpensesMember 2025-06-01 2026-05-31 0001718500 axil:GeneralsAndAdministrativeExpenseMember 2025-06-01 2026-05-31 0001718500 axil:MarketingServicesAndExtendedWarrantiesMember 2025-06-01 2026-05-31 0001718500 axil:MarketingServicesAndExtendedWarrantiesMember 2024-06-01 2025-05-31 0001718500 axil:CustomerMember 2025-06-01 2026-05-31 0001718500 axil:CustomerMember 2024-06-01 2025-05-31 0001718500 axil:CustomerDepositsMember 2024-05-31 0001718500 axil:DeferredWarrantyRevenueMember 2024-05-31 0001718500 axil:GiftCardsMember 2024-05-31 0001718500 axil:CustomerDepositsMember 2024-06-01 2025-05-31 0001718500 axil:DeferredWarrantyRevenueMember 2024-06-01 2025-05-31 0001718500 axil:GiftCardsMember 2024-06-01 2025-05-31 0001718500 axil:CustomerDepositsMember 2025-05-31 0001718500 axil:DeferredWarrantyRevenueMember 2025-05-31 0001718500 axil:GiftCardsMember 2025-05-31 0001718500 axil:CustomerDepositsMember 2025-06-01 2026-05-31 0001718500 axil:DeferredWarrantyRevenueMember 2025-06-01 2026-05-31 0001718500 axil:GiftCardsMember 2025-06-01 2026-05-31 0001718500 axil:CustomerDepositsMember 2026-05-31 0001718500 axil:DeferredWarrantyRevenueMember 2026-05-31 0001718500 axil:GiftCardsMember 2026-05-31 0001718500 axil:PromotionalDisplayRacksMember 2026-05-31 0001718500 axil:PromotionalDisplayRacksMember 2025-05-31 0001718500 us-gaap:FurnitureAndFixturesMember 2026-05-31 0001718500 us-gaap:FurnitureAndFixturesMember 2025-05-31 0001718500 us-gaap:ComputerEquipmentMember 2026-05-31 0001718500 us-gaap:ComputerEquipmentMember 2025-05-31 0001718500 srt:MinimumMember us-gaap:PropertyPlantAndEquipmentMember 2026-05-31 0001718500 srt:MaximumMember us-gaap:PropertyPlantAndEquipmentMember 2026-05-31 0001718500 us-gaap:PropertyPlantAndEquipmentMember 2026-05-31 0001718500 us-gaap:PropertyPlantAndEquipmentMember 2025-05-31 0001718500 srt:MinimumMember us-gaap:OfficeEquipmentMember 2026-05-31 0001718500 srt:MaximumMember us-gaap:OfficeEquipmentMember 2026-05-31 0001718500 us-gaap:OfficeEquipmentMember 2026-05-31 0001718500 us-gaap:OfficeEquipmentMember 2025-05-31 0001718500 us-gaap:AutomobilesMember 2026-05-31 0001718500 us-gaap:AutomobilesMember 2025-05-31 0001718500 axil:LicensingRightsMember 2026-05-31 0001718500 axil:LicensingRightsMember 2025-05-31 0001718500 us-gaap:CustomerRelationshipsMember 2026-05-31 0001718500 us-gaap:CustomerRelationshipsMember 2025-05-31 0001718500 us-gaap:TradeNamesMember 2026-05-31 0001718500 us-gaap:TradeNamesMember 2025-05-31 0001718500 axil:WebsiteMember 2026-05-31 0001718500 axil:WebsiteMember 2025-05-31 0001718500 axil:InternallyDevelopedSoftwareMember 2026-05-31 0001718500 axil:InternallyDevelopedSoftwareMember 2025-05-31 0001718500 axil:ProductCertificationTestingMember 2026-05-31 0001718500 axil:ProductCertificationTestingMember 2025-05-31 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2020-05-31 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2020-05-01 2020-05-18 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2021-06-01 2022-05-31 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2025-06-01 2026-05-31 0001718500 axil:EconomicInjuryDisasterLoanProgramMember 2024-06-01 2025-05-31 0001718500 us-gaap:StockOptionMember 2026-05-31 0001718500 us-gaap:StockOptionMember 2025-05-31 0001718500 srt:BoardOfDirectorsChairmanMember 2025-04-01 2025-04-08 0001718500 2022-06-01 2023-05-31 0001718500 us-gaap:SeriesAPreferredStockMember 2025-05-01 2025-05-24 0001718500 us-gaap:PreferredStockMember 2025-06-01 2026-05-31 0001718500 us-gaap:PreferredStockMember 2024-06-01 2025-05-31 0001718500 axil:N2022EquityIncentivePlanMember 2024-02-14 0001718500 axil:N2022EquityIncentivePlanMember 2024-02-02 2024-02-14 0001718500 axil:OneEmployeeMember 2026-03-18 0001718500 axil:OneConsultantsMember 2025-01-02 0001718500 axil:OneConsultantsMember 2024-11-13 0001718500 axil:TwoCompanyOfficersStockMember 2024-10-14 0001718500 us-gaap:StockOptionMember 2025-06-01 2026-05-31 0001718500 us-gaap:StockOptionMember 2024-06-01 2025-05-31 0001718500 axil:ThreeNonEmployeeDirectorsBoardMemberMember 2026-01-01 2026-01-15 0001718500 axil:ConsultantMember 2026-05-01 2026-05-07 0001718500 axil:ConsultantMember 2025-04-01 2025-04-10 0001718500 axil:ThreeNonEmployeeDirectorsBoardMemberMember 2025-01-01 2025-01-13 0001718500 axil:MemberOfTheBoardMember 2025-01-01 2025-01-13 0001718500 2024-11-13 0001718500 2024-11-01 2024-11-13 0001718500 axil:RestrictedStockAwardsMember 2025-06-01 2026-05-31 0001718500 axil:RestrictedStockAwardsMember 2024-06-01 2025-05-31 0001718500 axil:UnvestedRestrictedStockAwardsMember 2025-06-01 2026-05-31 0001718500 axil:UnvestedRestrictedStockAwardsMember 2026-05-31 0001718500 srt:MinimumMember 2024-06-01 2025-05-31 0001718500 srt:MaximumMember 2024-06-01 2025-05-31 0001718500 us-gaap:StockOptionMember 2024-05-31 0001718500 us-gaap:StockOptionMember 2023-06-01 2024-05-31 0001718500 axil:UnvestedRestrictedStockAwardsMember 2024-05-31 0001718500 axil:UnvestedRestrictedStockAwardsMember 2024-06-01 2025-05-31 0001718500 axil:UnvestedRestrictedStockAwardsMember 2025-05-31 0001718500 axil:IntrepidMember 2025-06-01 2026-05-31 0001718500 axil:IntrepidMember 2024-06-01 2025-05-31 0001718500 axil:IntrepidMember 2026-05-31 0001718500 axil:IntrepidMember 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember axil:OutsideTheUnitedStatesMember axil:AxilMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember country:CA axil:AxilMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember axil:OutsideTheUnitedStatesMember axil:AxilMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember country:CA axil:AxilMember 2024-06-01 2025-05-31 0001718500 us-gaap:AccountsReceivableMember us-gaap:ProductConcentrationRiskMember axil:CustomerOneMember 2025-06-01 2026-05-31 0001718500 us-gaap:AccountsReceivableMember us-gaap:ProductConcentrationRiskMember axil:CustomerOneMember 2024-06-01 2025-05-31 0001718500 us-gaap:AccountsReceivableMember us-gaap:ProductConcentrationRiskMember axil:CustomerTwoMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:VendorOneMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:VendorOneMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:VendorTwoMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axil:CustomerMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axil:CustomerOneMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axil:CustomerTwoMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axil:CustomerThreeMember 2025-06-01 2026-05-31 0001718500 axil:ConsolidatedNetSalesMember us-gaap:CustomerConcentrationRiskMember axil:CustomerMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember axil:CustomerMember 2024-06-01 2025-05-31 0001718500 axil:ConsolidatedNetSalesMember us-gaap:CustomerConcentrationRiskMember axil:CustomerMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember axil:OutsideTheUnitedStatesMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember country:CA 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember country:IT 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember axil:OutsideTheUnitedStatesMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember country:CA 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember country:IT 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:HairShampooMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:HairConditionerMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:BundledKitsMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:HairShampooMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:HairConditionerMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:BundledKitsMember 2024-06-01 2025-05-31 0001718500 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember axil:CustomerMember 2025-06-01 2026-05-31 0001718500 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember axil:CustomerMember 2024-06-01 2025-05-31 0001718500 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember axil:CustomerOneMember 2024-06-01 2025-05-31 0001718500 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember axil:CustomerTwoMember 2024-06-01 2025-05-31 0001718500 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember axil:CustomerThreeMember 2024-06-01 2025-05-31 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorsMember 2025-06-01 2026-05-31 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorOneMember 2025-06-01 2026-05-31 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorTwoMember 2025-06-01 2026-05-31 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorThreeMember 2025-06-01 2026-05-31 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorsMember 2024-06-01 2025-05-31 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorOneMember 2024-06-01 2025-05-31 0001718500 us-gaap:ProductConcentrationRiskMember axil:PurchasesMember axil:VendorTwoMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:InearProtectionDevicesMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:InearProtectionDevicesMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:OverEarProtectionDevicesMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:OverEarProtectionDevicesMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:AccessoriesOtherMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:AccessoriesOtherMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:ProductMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:ProductMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:ShampoosAndConditionersMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:ShampoosAndConditionersMember 2024-06-01 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:AncillaryProductsMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember axil:AncillaryProductsMember 2024-06-01 2025-05-31 0001718500 axil:HearingEnhancementAndProtectionMember 2025-06-01 2026-05-31 0001718500 axil:HairAndSkinCareMember 2025-06-01 2026-05-31 0001718500 axil:MarketingServicesMember 2025-06-01 2026-05-31 0001718500 axil:HearingEnhancementAndProtectionMember 2024-06-01 2025-05-31 0001718500 axil:HairAndSkinCareMember 2024-06-01 2025-05-31 0001718500 axil:HearingEnhancementAndProtectionMember 2026-05-31 0001718500 axil:HairAndSkinCareMember 2026-05-31 0001718500 axil:MarketingServicesMember 2026-05-31 0001718500 axil:HearingEnhancementAndProtectionMember 2025-05-31 0001718500 axil:HairAndSkinCareMember 2025-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember axil:CustomerMember 2025-06-01 2026-05-31 0001718500 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember axil:CustomerMember 2024-06-01 2025-05-31 0001718500 axil:HearingEnhancementAndProtectionMember axil:DirectToConsumerMember 2025-06-01 2026-05-31 0001718500 axil:HairAndSkinCareMember axil:DirectToConsumerMember 2025-06-01 2026-05-31 0001718500 axil:MarketingServicesMember axil:DirectToConsumerMember 2025-06-01 2026-05-31 0001718500 axil:DirectToConsumerMember 2025-06-01 2026-05-31 0001718500 axil:HearingEnhancementAndProtectionMember axil:RetailAndWholesaleMember 2025-06-01 2026-05-31 0001718500 axil:HairAndSkinCareMember axil:RetailAndWholesaleMember 2025-06-01 2026-05-31 0001718500 axil:MarketingServicesMember axil:RetailAndWholesaleMember 2025-06-01 2026-05-31 0001718500 axil:RetailAndWholesaleMember 2025-06-01 2026-05-31 0001718500 axil:HearingEnhancementAndProtectionMember axil:MarketingServicesMember 2025-06-01 2026-05-31 0001718500 axil:HairAndSkinCareMember axil:MarketingServicesMember 2025-06-01 2026-05-31 0001718500 axil:MarketingServicesMember axil:MarketingServicesMember 2024-06-01 2025-05-31 0001718500 axil:MarketingServicesMember 2024-06-01 2025-05-31 0001718500 axil:HearingEnhancementAndProtectionMember axil:DirectToConsumerMember 2024-06-01 2025-05-31 0001718500 axil:HairAndSkinCareMember axil:DirectToConsumerMember 2024-06-01 2025-05-31 0001718500 axil:MarketingServicesMember axil:DirectToConsumerMember 2024-06-01 2025-05-31 0001718500 axil:DirectToConsumerMember 2024-06-01 2025-05-31 0001718500 axil:HearingEnhancementAndProtectionMember axil:RetailAndWholesaleMember 2024-06-01 2025-05-31 0001718500 axil:HairAndSkinCareMember axil:RetailAndWholesaleMember 2024-06-01 2025-05-31 0001718500 axil:MarketingServicesMember axil:RetailAndWholesaleMember 2024-06-01 2025-05-31 0001718500 axil:RetailAndWholesaleMember 2024-06-01 2025-05-31 0001718500 axil:MarketingServicesMember 2024-06-01 2025-05-31 0001718500 country:US 2025-06-01 2026-05-31 0001718500 country:CA 2025-06-01 2026-05-31 0001718500 stpr:UT 2025-06-01 2026-05-31 0001718500 country:US 2024-06-01 2025-05-31 0001718500 axil:CostOfRevenuesMember 2025-06-01 2026-05-31 0001718500 axil:CustomDutiesMember 2025-06-01 2026-05-31 0001718500 axil:InterestMember 2025-06-01 2026-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE FISCAL YEAR ENDED MAY 31, 2026

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM TO

 

Commission file number: 001-41958

 

AXIL BRANDS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

47-4125218

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

   

9150 Wilshire Boulevard, Suite 245, Beverly Hills, California

 

90212
(Zip Code)

(Address of Principal Executive Offices)

   

 

(888) 638-8883 

(Registrant’s telephone number including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.0001 par value per share

 

AXIL

 

The NYSE American LLC

 

Securities registered pursuant to section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. 

YES ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act: 

YES ☐ No ☒ 

 

   

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

     

 

Large accelerated filer

Accelerated filer

Non-accelerated Filer

Smaller reporting company

   

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ¨ 

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ¨ 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). YES ☐ NO

 

As of November 28, 2025, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of the voting and non-voting common equity held by non-affiliates was $20,708,714. For purposes of this computation, all officers, directors and 10% beneficial owners of the registrant are deemed to be affiliates. Such determination should not be deemed to be an admission that such officers, directors or 10% beneficial owners are, in fact, affiliates of the registrant.

 

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

 

   

Shares Outstanding

Title of Class

 

August 14, 2026

Common Stock

 

6,822,681

 

Documents incorporated by reference: None

 

   

Table of Contents

 

Table of Contents

 

Cautionary Note Regarding Forward-Looking Information ii
   
PART I 1
ITEM 1. BUSINESS. 1
ITEM 1A. RISK FACTORS. 6
ITEM 1B. UNRESOLVED STAFF COMMENTS. 10
ITEM 1C. CYBERSECURITY. 10
ITEM 2. PROPERTIES. 11
ITEM 3. LEGAL PROCEEDINGS. 11
ITEM 4. MINE SAFETY DISCLOSURES. 11
   
PART II 12
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. 12
ITEM 6. [RESERVED] 12
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. 12
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. 20
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA. 20
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. 20
ITEM 9A. CONTROLS AND PROCEDURES. 20
ITEM 9B. OTHER INFORMATION. 21
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. 21
   
PART III 22
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. 22
ITEM 11. EXECUTIVE COMPENSATION. 26
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS. 30
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE. 32
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES. 33
   
PART IV 34
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES. 34
ITEM 16. FORM 10-K SUMMARY 37
   
SIGNATURES 38

 

 i 

Table of Contents

 

Cautionary Note Regarding Forward-Looking Information 

 

This Annual Report on Form 10-K, in particular Part II Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements represent our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any statements regarding our assumptions about financial performance and future outlook; the continuation of historical trends; the sufficiency of our cash balances for future liquidity and capital resource needs; the expected impact of changes in accounting policies on our results of operations, financial condition or cash flows; anticipated problems and our plans for future operations, including expected growth, the new marketing services business, and the economy in general or the future of the beauty and hair care industry and the hearing protection and ear bud business, all of which are subject to various risks and uncertainties.

 

There are a number of factors that could cause our actual results to differ, potentially materially, from those indicated in the forward-looking statements, many of which are outside of our control. They include: the impact of unstable market and general economic conditions on our business, financial condition and stock price, including inflationary cost pressures, the impact of tariffs and other trade restrictions and barriers, interest rate changes, unemployment rates, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, the possibility of an economic recession and other macroeconomic factors, geopolitical events and uncertainty, including the effects of the Ukraine-Russia conflict and conflicts in the Middle East, and other downturns in the business cycle or the economy; our financial performance and liquidity, including our ability to successfully generate sufficient revenue to support our operations; guidance provided by management, which may differ from our actual operating results; continued uncertainty with respect to U.S. trade policies and tariffs; our expectations regarding our financing arrangements and our ability to obtain additional capital if and as needed, including potential difficulties of obtaining financing due to market conditions resulting from geopolitical conditions and other economic factors; risks related to our operations and international markets, such as fluctuations in currency exchange rates, different regulatory environments, trade barriers and sanctions, exchange controls, and social and political instability; changes in the regulatory environment in which we operate, including environmental, health and safety regulations, including those related to sustainability; our ability to protect and defend our intellectual property; continuity and security of information technology infrastructure and the potential impact of cybersecurity breaches or disruptions to our management information systems; widespread outages, interruptions or other failures of operational, communication, and other systems; competition; our ability to retain our management and employees and the potential impact of labor shortages; demands on management resources; availability and cost of the raw materials we use to manufacture our products, including the impacts of inflationary cost pressures, tariffs, and ongoing supply chain disruptions and constraints, which have been, and may continue to be, exacerbated by the Russia-Ukraine conflict, the conflicts in the Middle East, and other geopolitical conflicts; additional tax expenses or exposures; product liability claims; the potential outcome of any legal or regulatory proceedings, including ongoing litigation, the disposition of which may have an adverse effect upon our business, financial condition, or results of operations; our ability to engage in acquisitions, investments, partnerships, strategic alliances or dispositions when desired; global or regional catastrophic events, including the effects of natural disasters, which may be worsened by the impact of climate change; effectiveness of our marketing strategy, demand for and market acceptance of our products, as well as our ability to successfully anticipate consumer trends and to realize anticipated benefits from our efforts to expand into new geographic markets and product lines and into offline sales, as well as our expansion into marketing services; labor relations; the potential impact of sustainability matters; implementation of environmental remediation matters; our ability to maintain effective internal control over financial reporting; and risks related to our common stock, including our ability to maintain our stock exchange listing.

 

 ii 

Table of Contents

 

When used in this Annual Report on Form 10-K and other reports, statements, and information we have filed with the Securities and Exchange Commission (the “SEC”), in our press releases, presentations to securities analysts or investors, or in oral statements made by or with the approval of an executive officer, the words or phrases “believes,” “can,” “may,” “will,” “expect,” “should,” “could,” “would,” “continue,” “anticipate,” “intend,” “likely,” “estimate,” “project,” “propose,” “plan,” “design,” “potential,” “focus” or similar expressions and variations thereof are intended to identify such forward-looking statements. However, any statements contained in this Annual Report on Form 10-K that are not statements of historical fact may be deemed to be forward-looking statements. Furthermore, such forward-looking statements speak only as of the date of this Annual Report on Form 10-K. We caution that these statements by their nature involve risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. These forward-looking statements are not guarantees of our future performance and involve risks, uncertainties, estimates and assumptions that are difficult to predict. We do not assume the obligation to update any forward-looking statement, except as required by applicable law. You should carefully evaluate such statements in light of factors described in this annual report.

 

The terms “we,” “us,” “our,” “AXIL,” and “the Company” refer to AXIL Brands, Inc. and, where applicable, its consolidated subsidiaries. 

 

This report also contains estimates and other statistical data obtained from publicly available information, including industry publications, relating to market size and growth and other data about our industry. Industry publications generally state that they obtain their information from sources that they believe to be reliable, but they do not guarantee the accuracy and completeness of the information. Similarly, while we believe that the statistical data and industry data are reliable, we have not independently verified the data. We have not sought the consent of the sources to refer to their reports appearing or incorporated by reference in this report. We did not commission any third party for collecting or providing data used in this report.

 

 iii 

Table of Contents

 

PART I

 

ITEM 1. BUSINESS.

 

General

 

AXIL is engaged in the manufacturing, marketing, sale, and distribution of high tech hearing and audio enhancement and protection products, professional quality hair and skin care products, and the delivery of marketing services. The Company changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024 and concurrently uplisted to the NYSE American stock exchange. The Company operates through its subsidiaries, AXIL Distribution Company (formerly Reviv3 Acquisition Corporation), Reviv3 ProCare Company, which was incorporated on February 24, 2026, and Sharper Vision Marketing Inc., which was incorporated on May 5, 2025. In February 2026, the Company formed Reviv3 ProCare Company, a wholly owned Delaware subsidiary, to support the strategic development of its Reviv3 hair and skin care business. 

 

The Company is not, and has never been, a shell company. AXIL operates on a fiscal year ending May 31.

  

Our Segments

 

We conduct our business primarily through three operating segments: hearing enhancement and protection, hair and skin care and marketing services. See Note 13 to our Consolidated Financial Statements in this report for financial information for these segments. We concentrate on attracting new customers and retaining existing customers to increase our total revenue. For the fiscal year ended May 31, 2026 (“fiscal year 2026”), the hearing enhancement and protection segment and the hair and skin care segment accounted for approximately 96% and 4% of our revenue, respectively. Our marketing services accounted for less than 1% of revenue.

 

Our Strategy

 

The Company is growing its business through the expansion of product lines serving various hearing protection markets, including outdoors, manufacturing, and construction, via its online platforms and an expanding network of retail points of sale. During fiscal year 2026, the Company broadened its retail presence to approximately 6,000 stores through expanded partnerships with big-box retailers, including Walmart. Additionally, AXIL’s full product line became available at certain U.S. Marine Corps Exchange (MCX) locations in the first quarter of fiscal 2027, extending access to military personnel and their families. The Company is further expanding its product offerings in the public safety and security markets with the introduction of the CRX digital hearing protection platform.

 

Sales are primarily driven by paid advertising, expansion of the distribution network, strategic partnerships, and retail sales. The Company continues to expand its marketing footprint across organic social media, affiliate marketing, and search engine optimization. The Company has increased its focus on opportunities in domestic and international distribution and retail sales and is allocating resources to expand its sales team based on capital performance and available opportunities.

 

Hearing Enhancement and Protection Segment

 

AXIL designs, manufactures, markets, and distributes advanced hearing enhancement and protection products for a wide range of applications and industries. Our product portfolio includes earplugs, earmuffs, earbuds, and outdoor speakers, many of which incorporate Bluetooth and wireless audio technologies. These products serve consumers in sporting goods, tactical, industrial, and recreational markets, as well as military, law enforcement, and federal agencies.

 

The Company also continued to invest in product innovation during fiscal year 2026. We currently offer 27 products across 114 stock keeping units (SKUs), with plans to expand the line. Product development is guided by consumer preferences and brand alignment, supported by third-party design services. Sales are primarily direct-to-consumer through our website (www.goaxil.com), as well as through third-party e-commerce platforms, dealers, and big box retail chains.

 

 -1- 

Table of Contents

 

Our key offerings include:

 

 

·

GS Extreme® 3.0 – Bluetooth-enabled earbuds for sound enhancement and hearing protection

 

·

AXIL® X30 LT – Dual-mode in-ear hearing protection and enhancement device with up to 25 decibel noise reduction

 

·

XCOR® True Wireless – Digital earbuds with touch control

 

·

MX Series Earmuffs – Bluetooth earmuffs with HearPRO™ digital hearing protection technology

 

·

X-PRO – X20 passive plugs and X30i passive plugs with SoundShield filter

 

AXIL holds three active patents, one patent pending, five registered trademarks and twelve pending trademark registrations related to this segment. For additional detail, see “Intellectual Property.” As the segment grows, we continue to enter new distribution and licensing agreements across target markets, including construction, aviation, agriculture, forestry, fitness, power sports, target shooting, motorcycling, and live event environments. We currently operate primarily in the U.S., with a growing presence in Canada, Europe, Australia, New Zealand, Asia and Africa.

 

The Company is growing the business as it continues to enter into new distribution and licensing agreements. During fiscal year 2026, AXIL expanded its retail presence through a broadened partnership with Walmart, with the MX PRO and MX Passive models launching across approximately 1,250 Walmart stores as of the filing of this report. Additionally, AXIL’s full product line is expected to become available at certain U.S. Marine Corps Exchange (MCX) locations in the first quarter of fiscal 2027, extending access to military personnel and their families. There is continued focus on public safety and security markets, as well as entertainment venues. Sales are primarily driven by paid advertising, the expansion of our distribution network, and strategic partnerships, with continued growth expected, including offline sales. The Company continues to expand our marketing footprint in organic social, affiliate, and search engine optimization. The Company has increased its focus on opportunities in domestic and international distribution and retail sales and is allocating resources to expand its sales team, based on capital performance and available opportunities.

 

Hearing Enhancement and Protection Competition:

 

The hearing enhancement and protection products are in a distinct market that overlaps between the consumer electronics and the hearing protection device sectors. We believe the global hearing protection devices market is growing due to the greater awareness of hearing loss. According to the Center for Disease Control and Prevention, 53% of noise-exposed workers report not wearing hearing protection. Demand for innovative products for hearing protection is rising as consumers seek devices that are both comfortable and offer superior hearing protection.

 

The hearing protection and enhancement segment competes with ISOtunes, Walker’s, SureFire, Sordin and others. Many of our competitors in this market have more broadly diversified product lines, well established supply and distribution systems, loyal customer bases and significant financial, marketing, research and development, and other resources. We believe our principal competitive advantages include: brand recognition; product technology and innovation; product quality and safety; price; breadth of product lines; network of technology and content partners; access to third party retailers; sales channels, distributors, retailers and OEM partners; and patent protection. 

 

Hair and Skin Care Segment

 

AXIL’s hair and skin care segment involves the outsourced manufacturing, marketing, and distribution of professional-grade products under the Reviv3 Procare® brand. We currently offer eight products across sixteen SKUs, with plans to expand the line in response to evolving customer needs. Our manufacturing is fulfilled through third-party co-packers and partners.

 

The product line includes shampoos, conditioners, scalp treatments, styling aids, and skin health solutions designed to promote healthy hair follicles and scalp function. Products are formulated to work as a system or individually, and include solutions for cleansing, conditioning, repair, protection, and volume enhancement.

 

 -2- 

Table of Contents

 

Sales are driven by a multi-channel strategy including:

 

 

·

Direct-to-consumer via our e-commerce site and third-party platforms

 

·

Domestic and international distributors

 

·

Professional salon partnerships

 

We currently maintain 14 distribution agreements across the U.S., Canada, Europe, and Asia, which are non-exclusive, and hold one registered trademark in this segment. In addition to expanding core distribution, including a partnership with a major national salon chain across Canada entered into during fiscal 2026, we are actively exploring growth through co-branding, private-label partnerships, and enhanced digital marketing initiatives.

 

Hair and Skin Care Competition:

 

The global hair care market continues to demonstrate significant growth potential. According to Mordor Intelligence, the global hair care market is expected to increase from approximately $82.5 billion in 2026 to $108.6 billion by 2031, reflecting a projected compound annual growth rate of approximately 5.7%. North America currently represents the largest regional market, while Asia-Pacific is expected to experience the fastest growth during the forecast period.

 

The Company believes these industry trends support continued demand for products addressing hair health, hair loss, scalp care, and related wellness needs.

 

The hair and skin care segment competes with Keranique, Zenagen, Revita and others. Many of our competitors in this market have more broadly diversified product lines, well established supply and distribution systems, loyal customer bases and significant financial, marketing, research and development and other resources. We believe our principal competitive advantages include product quality, online marketing, and drug-free solutions for healthy scalp and hair.

 

Key Customers

 

For the hearing enhancement and protection segment which accounted for 96% of consolidated net revenues, one customer accounted for 23% of our net revenues in the fiscal year ended May 31, 2026. Approximately 65% of our consolidated net revenues were direct-to-consumer through our owned e-commerce sites and third-party online marketplaces for the fiscal year ended May 31, 2026, compared with approximately 80% for the fiscal year ended May 31, 2025. During fiscal year 2026, the Company expanded its brick-and-mortar retail presence, including through an expanded partnership with Walmart across approximately 1,250 stores. Subsequent to fiscal year end, the Company announced the addition of certain U.S. Marine Corps Exchange (MCX) locations as a distribution channel, with availability expected to begin in July 2026. Walmart did not individually account for more than 10% of net sales in fiscal year 2026, and we believe these relationships represent significant new retail opportunities for the Company.

 

As is customary in the industry, none of our customers are under any obligation to continue purchasing products from us in the future.

 

Key Suppliers

 

Similar to other specialty retailers, we purchase a significant portion of our total inventory from a limited number of vendors. During fiscal year 2026, a single vendor accounted for 79% of total purchases in our hearing enhancement and protection segment. In our hair and skin care segment, three vendors accounted for 91% of total purchases in the respective segment, each accounting for 62%, 18%, and 11%, respectively. The loss of any one or more of these key vendors or our failure to establish and maintain relationships with these and other vendors could have a material adverse effect on our results of operations and financial condition. Our relationships with our vendors allowed us to maintain a competitive in-stock position.

 

 -3- 

Table of Contents

 

Customer Service and Support

 

Key elements of our customer service approach are listening to customers, empathizing with their concerns, responding timely to their requests, and following up with them to make sure any issues have been properly addressed. In order to ensure that sufficient quality of service is provided, we use a customer service platform that integrates all of our systems to provide complete and timely data and tracks all support tickets and conversations with customers. Our customer service manager performs regular monthly reviews of performance metrics and reviews processes. 

 

Governmental Regulation

 

We are subject to a variety of laws, rules and regulations in numerous jurisdictions within the U.S., Canada, Europe, Australia, New Zealand, Asia, and Africa. These laws, rules and regulations cover several diverse areas including consumer health and safety, and employee health and safety. These U.S. federal, state, and foreign laws and regulations, which in some cases can be enforced by private parties in addition to government entities, are constantly evolving and can be subject to significant change. The compliance costs and operational burdens imposed by these laws and regulations could be significant. As a result of the often rapidly evolving changes, the application, interpretation, and enforcement of these and other laws and regulations are often uncertain and may be interpreted and applied inconsistently from jurisdiction to jurisdiction and inconsistently with our current policies and practices. We are committed to conducting our business in accordance with applicable laws, rules and regulations.

 

Environmental Matters: We believe that we are in compliance with applicable foreign, federal, state, and local laws, rules and regulations relating to the protection of the environment, and that continued compliance will not have any material effect on our capital expenditures, earnings, or competitive position.

  

Intellectual Property

 

We intend to protect our technology by filing patent applications for the technologies that we consider important to our business. We also rely on trademarks, trade secrets, copyrights and unpatented know-how to protect our proprietary rights.

 

We recognize the value of our intellectual property and have taken, and will continue to take, appropriate measures to safeguard it against misappropriation. There can be no assurance, however, that such actions will provide meaningful protection from competition. In the absence of intellectual property protection, we may be vulnerable to competitors who attempt to copy or imitate our products or processes.

 

While we believe that our patents and other proprietary rights are important to our business, we also believe that, due to the rapid pace of technological change in the markets we serve, the successful manufacture and sale of our products also depends upon our engineering, manufacturing, marketing and servicing skills.

 

It is our practice to require that all of our employees and third-party product development consultants assign to us all rights to inventions or other discoveries relating to our business that were made while working for us. In addition, all employees and third-party product development consultants agree not to disclose any private or confidential information relating to our technology, trade secrets or intellectual property.

 

At May 31, 2026, we held three active U.S. patents and had one pending U.S. patent application covering various aspects of our technology. Our U.S. patents expire at various times beginning in 2035 and extending through 2038. During the fiscal year ended May 31, 2026, none of our U.S. patents expired.

 

We have six federally registered trademarks and 12 trademarks pending registration, which we consider to be of material importance to our business. The registrations for these trademarks are in good standing with the U.S. Patent & Trademark Office. Our trademark registrations must be renewed at various times, and we intend to renew our trademarks, as necessary, for the foreseeable future.

 

 -4- 

Table of Contents

 

In addition, we own reviveprocare.com and www.goaxil.com. As with phone numbers, we do not have and cannot acquire any property rights to an Internet address. The regulation of domain names in the United States and in other countries is also subject to change. Regulatory bodies could establish additional top-level domains, appoint additional domain name registrars or modify the requirements for holding domain names. As a result, we might not be able to maintain our domain names or obtain comparable domain names, which could harm our business.

 

Seasonality

 

While our business is not subject to substantial seasonal fluctuations, we do experience typical variations in consumer demand around certain holidays and promotional periods. These fluctuations are consistent with industry norms and do not materially impact our overall operating results.

 

Human Capital Management

 

As of May 31, 2026, we had thirteen full-time employees and two part-time employees, all of whom were employed in the United States and none employed outside the United States. None of our employees are covered by collective bargaining agreements or work councils. Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors and consultants. Overall, we consider our employee relations to be good and believe our culture to be central to the success of the Company.

  

Health and Safety: The health and safety of our employees is of utmost importance to us. We are continuing to enhance our safety program with additional training and internal risk and hazard assessments. We conduct policy and procedure reviews to ensure compliance with health and safety guidelines and regulatory requirements. We provide protective gear (e.g., eye protection, masks, and gloves) as required by applicable standards and as appropriate. Our goal is to achieve a level of work-related injuries as close to zero as possible through continuous investment in our safety program. 

 

Compensation and Benefits: Our compensation and benefits program is designed to attract and reward individuals who demonstrate the ability and desire to enhance our workplace culture, support our values, drive our operational and strategic goals, and create long-term value for our stockholders.

 

Our Office and Corporate History

 

Our principal executive office is located at 9150 Wilshire Boulevard, Suite 245, Beverly Hills, California 90212. Our telephone number is (888) 638-8883. Axil Brands, Inc. was incorporated in the State of Delaware on May 21, 2015 as a reorganization of Reviv3 Procare, LLC, which was organized on July 31, 2013.

 

Available Information

 

We file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy statements and other information with the Securities and Exchange Commission (“SEC”). Our filings with the SEC are available on the SEC’s website at www.sec.gov. We also maintain websites at www.goaxil.com and reviveprocare.com. We make available, free of charge, in the Investors section of our website, documents we file with or furnish to the SEC, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports. We make this information available as soon as reasonably practicable after we electronically file such materials with, or furnish such information to, the SEC. The information found on our website is not part of this or any other report we file with, or furnish to, the SEC. Any reference to our websites in this Form 10-K is intended to be an inactive textual reference only. Copies of such documents are available in print at no charge to any stockholder who makes a request. Such requests should be made to our corporate secretary at our corporate headquarters, 9150 Wilshire Boulevard, Suite 245, Beverly Hills, California 90212.

 

 -5- 

Table of Contents

 

ITEM 1A. RISK FACTORS.

 

Investing in our securities involves a high degree of risk. The following are material factors known to us that could adversely affect our business, financial condition, or operating results, as well as adversely affect the value of an investment in our common stock. These disclosures reflect the Company’s beliefs and opinions as to factors that could materially and adversely affect the Company and its securities in the future. If any of the following risks materialize, our business, financial condition, operating results, or prospects could be materially and adversely affected. Disclosure of risks should not be interpreted to imply that the risks have not already materialized, and there may be additional risks that are not presently material or known. References to past events are provided by way of examples only and are not intended to be a complete listing or a representation as to whether or not such factors have occurred in the past or their likelihood of occurring in the future. You should carefully consider the risks described below, together with all of the other information contained in this Annual Report on Form 10-K and our other filings with the SEC, before making an investment decision.

 

Risks Related to Our Business and Operations

 

Our future operations and growth depends on successful execution of our strategic initiatives and market acceptance of our products. Our ability to grow depends on our ability to execute our growth strategy, which includes expanding into retail channels and international markets and expanding our sales team. These initiatives require significant commitments of management and capital investments and involve operational complexity. Failure to effectively execute our growth strategy could result in missed opportunities and financial losses, which could have a material adverse effect on our business, financial condition, or results of operations. In addition, if our existing or new products fail to achieve or maintain market acceptance, we may be unable to remain competitive and our business, results of operations, and financial condition could be harmed.

 

We generate a significant portion of our sales from a limited number of customers. For our hearing enhancement and protection segment, one customer accounted for 23% of consolidated net revenues and 69% of segment accounts receivable for fiscal year 2026. While we are working to grow our retail and wholesale channel, we expect that sales of our products to a limited number of customers will continue to account for a high percentage of our net revenues for the foreseeable future. The concentration of our customer base increases risks related to the financial condition of our customers, and the deterioration in financial condition of a single customer or the failure of a single customer to perform their obligations could have a material adverse effect on our results of operations and cash position. If any such customers change their business requirements or focus, vendor selection, or purchasing behavior, they may delay, suspend, reduce or cancel their purchases of our products or services and our business, financial condition, and results of operations may be adversely affected.

 

We are highly dependent on a small number of personnel. As of May 31, 2026, we had thirteen full-time employees and two part-time employees. We rely on a limited number of executive officers and key personnel, including Jeff Toghraie, our Chief Executive Officer and Chairman, and Jeff Brown, our Chief Financial Officer, Chief Operating Officer, and Director, to run our business. The loss of services of either of these executives or other key personnel could materially impair our ability to meet reporting obligations, maintain effective internal controls, manage liquidity, or conduct operations. Because of our limited personnel structure, the unexpected departure or unavailability of key personnel could have a disproportionately adverse impact on our financial condition and ability to continue operations.

 

 -6- 

Table of Contents

 

Risks Related to Our Supply Chain and Cost Structure

 

We are subject to inflationary pressures and supply chain risks. Increases in raw material costs, transportation delays, or disruptions in supplier relationships could increase expenses or limit our ability to deliver products on time. Any inability to source sufficient raw materials for our business in a timely and cost-effective manner, or at all, could significantly impair our ability to fulfill customer orders and sell our products, which could negatively impact margins and customer satisfaction.

 

Inaccurate forecasting may lead to excess inventory or stockouts. To ensure adequate inventory supply, we must forecast inventory needs and place orders sufficiently in advance with our suppliers based on our estimates of future demand for particular products. Our ability to meet customer demand depends on accurate sales forecasting, which could be affected by many factors, including changes in consumer preferences for our and our competitors’ products. If we overestimate demand, we may carry obsolete or excess inventory, which could result in inventory write-downs or write-offs. If we underestimate demand, we may miss sales opportunities and have unfulfilled orders, which could negatively impact our customer relationships and result in lost revenues.

 

We rely on a limited number of suppliers for certain key components and raw materials. Our ability to manufacture and deliver products depends on a small number of third-party suppliers, some of whom provide proprietary or difficult-to-substitute materials. Any disruption, delay, capacity constraint, or deterioration in the financial condition of these suppliers could adversely impact our operations. We may not be able to quickly secure alternative sources for key components and raw materials on commercially reasonable terms, which could lead to production delays, increased costs, or inability to meet customer demand.

 

Risks Related to Legal and Regulatory Matters

 

Our business and the products we sell are subject to complex and evolving regulations. We are required to comply with various laws and regulations at the local, regional, state, federal, and international levels. These laws and regulations change frequently, and such changes can impose significant costs and other burdens of compliance on our business. Any changes in regulations, the imposition of additional regulations, or the enactment of any new legislation that affects employment/labor, trade, product safety, transportation/logistics, energy costs, health care, tax, environmental issues, including the impact of climate change, or compliance with applicable anti-bribery laws, among other things, could have an adverse impact on our financial condition and results of operations. In addition, changes in enforcement priorities by governmental agencies charged with enforcing existing laws and regulations could increase our cost of doing business. Furthermore, our products are regulated by various U.S. and international authorities. As a result, our products could be subject to recalls and other remedial actions. Product safety, labeling, and licensing concerns may result in us voluntarily removing selected products from our inventory. Recalls or the voluntary removal of our products could result in lost sales, potential harm to our reputation, increased customer service costs, and legal expenses. In addition, changes in labeling, safety, or marketing laws may increase compliance costs or limit our ability to sell certain products. Non-compliance with any of these laws could result in fines, product recalls, or reputational damage, which could have a material adverse effect on our business, results of operations, and financial condition.

 

 -7- 

Table of Contents

 

Changes in U.S. and international trade policies, including tariffs and import rules, could increase our costs and disrupt operations. We source a significant portion of our products and components from international suppliers, and we sell our products in a number of countries. The current trade environment remains highly fluid and uncertain. The U.S. government has imposed, modified, and in certain cases temporarily suspended significant tariffs on goods imported from China and other countries, and further changes to tariff policy may occur with limited notice. Due to the uncertainty surrounding the ultimate scope and duration of applicable tariffs, during fiscal year 2026 the Company reversed charges only on those tariff costs for which it received refunds. Subsequent to fiscal year end, the Company received approximately $910,000, the full amount of refunds of duties previously paid under the International Emergency Economic Powers Act (“IEEPA”), including interest. Future tariff increases, the imposition of reciprocal tariffs or trade restrictions by other countries, the elimination of existing exemptions, or adverse changes to trade agreements could materially increase our landed costs, compress margins, and require us to raise prices or absorb additional expenses. If we are unable to offset these cost increases or pass them on to customers, our margins and financial results could be materially adversely impacted.

 

We may not be able to maintain effective internal control over financial reporting. As a public company, we are required to design, implement, and maintain effective internal control over financial reporting in accordance with the Sarbanes-Oxley Act, including ongoing evaluation, remediation of deficiencies, and adaptation to changes in our operations, systems, and regulations. We regularly assess risks, monitor controls, and implement enhancements to help ensure the accuracy and timeliness of our financial reporting; however, we cannot guarantee that our controls will prevent or detect all errors or noncompliance. Failure to maintain effective controls could result in material misstatements, financial restatements, regulatory scrutiny, increased costs, and loss of investor confidence. 

 

Risks Related to Our Capital and Securities

 

We may need additional capital, which may not be available or may dilute existing stockholders. To support our operations or strategic plans, we may need to raise capital through equity or debt financings. There can be no assurance that such additional funding will be available on terms attractive to us, or at all. If we cannot secure funding on acceptable terms, or at all, we may be forced to delay growth or other strategic initiatives, which could have an adverse effect on our business, financial condition, and results of operations. If additional funding is raised through the issuance of equity or convertible securities, holders of our common stock could suffer significant dilution, and any new shares we issue could have rights, preferences, and privileges superior to those of our common stock.

 

The issuance of convertible securities may dilute our common stockholders. We have previously issued Series A Convertible Preferred Stock in connection with acquisitions. Conversions of these preferred shares into common stock, or the issuance of shares in connection with other convertible securities that we may issue in the future, could significantly dilute common stockholders and negatively affect the market price of our common stock.

 

Our common stock price may be volatile and as a result may not be attractive to investors. Our stock price has been and may continue to be volatile due to a variety of factors, many of which are beyond our control, including, but not limited to, the following:

 

 

·

our actual or anticipated financial performance;

 

·

changes in the supply or demand of our products;

 

·

our ability to execute our growth strategy;

 

 -8- 

Table of Contents

 

 

·

speculation about our business in the press or investor community;

 

·

the degree of trading liquidity in our common stock, including our ability to remain listed on the NYSE American;

 

·

stock market price and volume fluctuations of other publicly traded companies, and in particular, companies that are in our industry;

 

·

investor perceptions of our industry or our prospects;

 

·

macroeconomic trends and conditions;

 

·

announcements by us or our competitors of new product offerings, significant acquisitions, or strategic partnerships; or

 

·

additions and departures of key personnel.

 

In addition, the stock market in general may experience significant price and volume fluctuations, which may be unrelated to the operating performance of particular companies but could cause declines in the market price of our common stock. The price of our common stock could fluctuate based upon factors that have little or nothing to do with our Company or its performance.  

 

Risks Related to Technology and Cybersecurity

 

A failure of our IT systems or a cybersecurity breach could disrupt our business. We rely on IT infrastructure, including hardware, networks, software, digital platforms and third-party systems to operate our business and communicate with customers. These uses give rise to cybersecurity risks, including security breaches, system disruption, theft, and inadvertent release of information. We have implemented measures to prevent and mitigate cybersecurity breaches. To date, we are not aware of any cybersecurity incidents that have had or are reasonably expected to have a material adverse effect on our operations. However, we or our third-party service providers may experience cybersecurity incidents in the future. In addition, as artificial intelligence capabilities improve and are increasingly adopted, they may be used to identify vulnerabilities and craft increasingly sophisticated cybersecurity attacks, and vulnerabilities may be introduced from the use of artificial intelligence by us, our customers, suppliers and other business partners and third-party providers. While we have implemented various security measures, we cannot guarantee that such measures will be effective or sufficient to prevent a cyberattack, and future cyberattacks could still occur and could go undetected and persist for an extended period of time. There can be no assurance that our operations will not be materially adversely impacted by future cybersecurity incidents, and there is a risk that we may incur significant costs in protecting against or remediating cyberattacks or other cybersecurity breaches. A significant IT failure, data breach, or cyberattack could harm our reputation, disrupt operations, and expose us to legal or regulatory liabilities. In addition, the theft, destruction, loss, misappropriation, release of sensitive or confidential information, or interference with the IT infrastructures of third parties on which we rely, including suppliers and customers, could result in a disruption to our supply chain, which could adversely affect our business, financial condition, or results of operations. We also incur costs in order to comply with cybersecurity or data privacy regulations or with requirements imposed by business partners. Data privacy and cybersecurity laws in the United States and internationally are constantly changing, and the implementation of these laws has become more complex. Any security breach, whether successful or not, would harm our reputation and could damage our competitive position and cause the loss of customers. In addition, any such breach, or any material failure on our part to comply with applicable laws, could subject us to litigation, government investigation or enforcement actions or other regulatory sanctions, regulatory penalties or fines, or costly response measures.

 

 -9- 

Table of Contents

 

Risks Related to Macroeconomic and External Conditions

 

Economic downturns or shifts in consumer behavior may reduce consumer demand for our products. Unfavorable economic factors that are beyond our control, including those impacting discretionary spending, may reduce consumer demand for our products. These factors include, but are not limited to, economic uncertainty, including potential recession, inflation, , interest rate uncertainty, tariffs, supply chain and labor disruptions, unemployment rates, labor and materials shortages, banking instability, political and social unrest, geopolitical events and uncertainty, foreign currency exchange rate fluctuations, and changing tax rates and policies. Any one or a combination of these factors could adversely affect consumer spending and preferences. If consumer demand for our products decreases, our revenue and profitability may be materially and adversely impacted.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS.

 

Not applicable.

  

ITEM 1C. CYBERSECURITY.

 

Cybersecurity is an important part of our Enterprise Risk Management (“ERM”) program, and the Company seeks to address cybersecurity risks through a comprehensive, cross-functional approach. The Company’s cybersecurity policies, standards, processes, and practices for assessing, identifying and managing material risks from cybersecurity threats and responding to cybersecurity incidents are continuously analyzed and updated. The Company has established controls and procedures, including an Incident Response Plan, that provide for the identification, notification, escalation, communication, and remediation of data security incidents at appropriate levels so that decisions regarding the public disclosure and reporting of such incidents can be made by management in a timely manner. As part of its cybersecurity program, the Company utilizes firewalls, anti-malware, intrusion prevention and detection systems, and access controls. The Company periodically assesses and tests its policies, standards, processes and practices that are designed to address cybersecurity threats and incidents, reports results of such assessments to the Company’s Board of Directors (the “Board”), and periodically adjusts the Company’s cybersecurity program based on these exercises. The Company engages third parties to conduct such testing. The Company seeks to identify and oversee cybersecurity risks presented by third parties and their systems from a risk-based perspective by implementing a comprehensive risk assessment framework, conducting regular audits, and establishing stringent security protocols and standards for third-party engagements. This approach helps ensure that potential vulnerabilities are identified and mitigated, thereby protecting the Company’s assets and maintaining robust security throughout its supply chain. The Company also conducts cybersecurity training for employees (including mandatory training programs for system users).

 

Our executive management team is responsible for assessing and managing risks from cybersecurity threats to the Company. In addition, in light of the pervasive and increasing threat from cyberattacks, the Board and the Audit Committee, with input from management, assesses the Company’s cybersecurity threats and the measures implemented by the Company in an effort to mitigate and prevent cyberattacks. The Audit Committee consults with management regarding ongoing cybersecurity initiatives, and requests management report to the full Board regularly on their assessment of the Company’s cybersecurity program and risks. Both the Audit Committee and the full Board receive regular quarterly reports from management on cybersecurity risks and timely reports regarding any significant cybersecurity incident, as well as ongoing updates regarding any such incident until it has been addressed.

 

 -10- 

Table of Contents

 

While the Company faces a number of cybersecurity risks in connection with its business, as of the date of this report, the Company is not aware of any risks from cybersecurity threats that have materially affected or are reasonably likely to materially affect the Company, including its business strategy, results of operations, or financial condition. However, there can be no assurance that the Company, or its third-party service providers, will not experience a cybersecurity threat or incident in the future that could materially adversely affect the Company, including its business strategy, results of operations, or financial condition.   

 

ITEM 2. PROPERTIES.

 

We lease approximately 2,793 rentable square feet of office space at 9150 Wilshire Boulevard, Suite 245, Beverly Hills, California 90212, serving as our principal offices. The lease commenced on November 1, 2024, and expires on January 31, 2029. Monthly base rent was $11,168 for the first 12 months, with scheduled increases thereafter. Rent is abated in months 2, 15, and 30. We believe this office space is in good condition and adequately supports our administrative and corporate functions.

 

We also lease approximately 6,050 square feet of office and warehouse space at 777 S. Auto Mall Drive, Unit 107, American Fork, Utah 84003, under a sublease agreement that began on October 1, 2024, and continues through September 30, 2027. Base rent was $7,684 per month for the first 12 months, with escalations thereafter. Rent was abated for three months in the first year. Additional estimated monthly charges of $1,210 are assessed for common area maintenance, taxes, and insurance. This facility supports operations for our three primary segments.

We believe that these facilities are in good condition, adequately maintained, and suitable to meet our current business needs.

 

ITEM 3. LEGAL PROCEEDINGS.

 

From time to time, we become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings are inherently uncertain, and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

 -11- 

Table of Contents

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 

Our common stock trades on the NYSE American, under the symbol “AXIL.”

 

Securities outstanding and holders of record

 

On August 14, 2026, the total common shares issued and outstanding were 6,822,681 and we had 128 stockholders of record of our common stock.

 

Dividend Policy

 

We have never paid any cash dividends on our common stock and we do not expect to pay cash dividends on our common stock in the foreseeable future. Any future determination to pay dividends on our common stock will be at the discretion of our Board and will depend on our financial condition, results of operations, capital requirements, applicable restrictions in our Certificate of Incorporation, applicable restrictions in our Bylaws, contractual limitations, and other factors that our Board deems relevant.

 

Recent Sales of Unregistered Securities

 

There were no unregistered securities issued during the fourth quarter of fiscal year 2026.

 

Issuer Purchases of Equity Securities

 

We did not repurchase any of our equity securities during the fourth quarter of fiscal year 2026.

 

ITEM 6. [RESERVED]

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The following discussion should be read in conjunction with our financial statements and the notes thereto included in this report under Item 8 Financial Statements and Supplementary Data. The results shown herein are not necessarily indicative of the results to be expected in any future periods. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements. Please see the section entitled “Cautionary Note Regarding Forward-Looking Information” above for more information regarding the risks associated with forward-looking information.

 

Overview

 

The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech, innovative hearing and audio enhancement and protection products that provide cutting-edge solutions for people with varied applications across many industries, professional quality hair and skin care products under various trademarks and brands, and the delivery of marketing services to support both its owned brands and third-party clients.

 

Beginning in the three months ended February 28, 2026, we operate in three reportable segments: (i) hearing enhancement and protection, (ii) hair and skin care, and (iii) marketing services.

 

 -12- 

Table of Contents

 

Through our hearing enhancement and protection segment, we design, innovate, engineer, manufacture, market and service specialized systems in hearing enhancement, hearing protection, wireless audio, and communication. Through our hair and skin care segment, we manufacture, market, sell, and distribute professional quality hair and skin care products. Our marketing services segment is conducted through our wholly owned subsidiary, Sharper Vision Marketing Inc., which was formed to leverage our direct-to-consumer expertise in support of both our internal brands and third-party clients. This segment is focused on delivering performance-driven marketing solutions and represents an expansion of our capabilities to drive growth and enhance brand visibility.

 

Our overall business strategy centers on building strong market awareness of our products across multiple sales channels. We primarily drive revenue and brand recognition through targeted online marketing and advertising campaigns. This awareness is designed to create a multiplier effect. By expanding the number of points of sale both online and offline we aim to capture more sales and customers for every dollar spent on advertising. We aim to optimize customer acquisition by converting the market awareness generated through paid campaigns into purchases across a broader range of retail and distribution locations. 

 

In addition to growing our overall distribution and retail footprint, the Company has reached a significant milestone in its wholesale channel strategy by securing several strategic supply agreements with big box retail chains. These agreements generated multiple purchase orders in fiscal 2026. While there can be no assurance that additional purchase orders will be received or regarding the timing or volume of fulfillment, we expect this expanded national retail presence to drive meaningful revenue growth and significantly enhance brand visibility among a much wider customer base.

 

Business Update

 

During fiscal year 2026, the Company expanded its retail distribution network. During fiscal year 2026 the Company announced an expanded partnership with Walmart to include the MX PRO and MX Passive hearing protection models across approximately 1,250 Walmart store locations nationwide, building on an initial rollout completed earlier in the fiscal year. In March 2026, the Company announced the introduction of its GSX 3.0 and XCOR Pro products to Sportsman's Warehouse, a premier specialty outdoor retailer, across approximately 70 retail locations and its e-commerce platform. Subsequent to fiscal year end, in June 2026, the Company announced that its full product line is expected to be available at U.S. Marine Corps Exchange (MCX) locations beginning in the first quarter of fiscal 2027, extending the Company's reach to U.S. military personnel, their families, and authorized patrons. Collectively, these partnerships, along with other retail distribution arrangements we have entered into, represent a meaningful expansion of the Company's brick-and-mortar retail presence across mass, specialty, and military channels.

 

The Company also continued to invest in product innovation during fiscal year 2026. In December 2025, the Company announced the MX II Series earmuffs, a next-generation over-the-ear hearing protection and enhancement platform powered by the Company's proprietary SonicShieldX™ technology. The flagship MX II PRO, featuring advanced Bluetooth connectivity and automatic noise compression, was made available for preorder in January 2026, with deliveries commencing in February 2026. Additional variants in the MX II Series were released in May 2026. In March 2026, the Company unveiled the AXIL CRX, an in-ear solution combining hearing protection with modular connectivity options, which became available in May 2026. These launches reflect the Company's continued focus on expanding its product portfolio across multiple form factors and price points within the hearing protection and enhancement category.

 

 -13- 

Table of Contents

 

The tariff environment remains fluid and uncertain. During fiscal year 2026, the Company paid approximately $900,000 in duties under the IEEPA on imported goods. In February 2026, the U.S. Supreme Court held that IEEPA does not authorize certain of these tariffs, and subsequent court orders have directed U.S. Customs and Border Protection (“CBP”) to develop a refund process for affected entries. At May 31, 2026, the Company’s refund claims had not been accepted or approved by CBP in full, and based on the uncertainty surrounding refund claims at the time, the Company concluded that recovery of the full refund claims amount was not probable and that the associated gain was neither realized nor realizable. As a result, the Company recognized only those tariff refunds actually received or approved by the CBP during the fiscal year end, in accordance with ASC 450-30, which precludes the recognition of gain contingencies until the gain is realized or realizable. Subsequent to May 31, 2026, the Company received IEEPA duty refunds of approximately $910,000, including interest, which were not recognized in the year ended May 31, 2026 and which the Company expects to recognize in the fiscal year ending May 31, 2027 as a reduction of cost of revenues, a reduction of the carrying value of inventory, and other income, as applicable. That benefit will favorably affect gross margin in the period recognized on a basis that is not indicative of underlying operating performance. See Note 10 in the accompanying notes to the consolidated financial statements. No refund claims of IEEPA duties remain outstanding as of the date of this filing. Separately, following the Supreme Court's decision, a new tariff surcharge of at least 10% on all imports, subject to certain exceptions, was imposed under Section 122 of the Trade Act of 1974, effective February 24, 2026. Effective upon the expiration of these tariffs in July 2026, new tariff rates generally ranging from 10% to 12.5% on most imports from certain countries were imposed pursuant to Section 301 of the Trade Act of 1974. The scope and duration of current and future tariff measures remain uncertain and could continue to impact the Company's cost of goods and results of operations.

 

Results of Operations

 

Our results of operations are summarized below.

 

 

 

Fiscal Year Ended
May 31,

2026

 

 

Fiscal Year Ended
May 31,

2025

 

Revenues, net

 

$

30,847,570

 

 

$

26,257,522

 

Cost of revenues

 

 

9,467,823

 

 

 

7,615,954

 

Gross profit

 

 

21,379,747

 

 

 

18,641,568

 

Total operating expenses

 

 

18,402,704

 

 

 

17,480,203

 

Income from operations

 

 

2,977,043

 

 

 

1,161,365

 

Net income after tax

 

$

2,699,349

 

 

$

854,988

 

 

We calculate EBITDA by taking net income calculated in accordance with accounting principles generally accepted in the United States (“GAAP”), and adjusting for income taxes, interest income or expense, and depreciation and amortization. We calculate adjusted EBITDA as EBITDA, further adjusted for stock-based compensation. Adjusted EBITDA is also presented as a percentage of revenue, which is calculated by dividing the non-GAAP adjusted EBITDA for a period by revenue for the same period. Other companies may calculate EBITDA and adjusted EBITDA differently, limiting the usefulness of these measures for comparative purposes. We believe that these non-GAAP measures of financial results provide useful information regarding certain financial and business trends relating to our financial condition and results of operations, and management considers EBITDA and adjusted EBITDA important indicators in evaluating our business on a consistent basis across various periods for trend analyses. These non-GAAP financial measures exclude significant expenses and income that are required by GAAP to be recorded in our financial statements and are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. Investors should review the reconciliation of these non-GAAP financial measures to the comparable GAAP financial measure included below. Investors should not rely on any single financial measure to evaluate our business. 

 

 -14- 

Table of Contents

 

 

 

Fiscal Year Ended May 31,

2026

 

 

Fiscal Year Ended May 31,

2025

 

             

 Net income (GAAP)

 

$

2,699,349

   

$

854,988

 

 Provision for income taxes

   

440,310

     

453,828

 

 Interest income, net

   

(132,131

)

   

(135,915

)

 Depreciation and amortization

   

246,723

     

148,498

 

 Total EBITDA (Non-GAAP)

   

3,254,251

     

1,321,399

 

 

 

 

 

 

 

 

 

 

 Adjustments:

 

 

 

 

 

 

 

 
                 

 Stock-based compensation

   

785,160

     

1,108,934

 
                 

 Total Adjusted EBITDA (Non-GAAP)

 

$

4,039,411

   

$

2,430,333

 
 

 

 

 

 

 

 

 

 

 Revenues, net (GAAP)

 

$

30,847,570

   

$

26,257,522

 
                 

Adjusted EBITDA as a percentage of Revenues, net (Non-GAAP)

   

13.1

%

   

9.3

%

 

Revenues, net increased by $4,590,048 or 17.5%, from $26,257,522 in the year ended May 31, 2025 to $30,847,570 for the year ended May 31, 2026. The increase in net sales was primarily driven by sales to big box retail chains in our hearing enhancement and protection equipment segment.

 

We disaggregate net revenues into three sales channels, which correspond to the way management evaluates commercial performance and to the categories presented in Note 13 to our consolidated financial statements: (i) Direct-to-consumer (“DTC”), comprising sales through our owned e-commerce sites and third-party online marketplaces; (ii) retail and wholesale, comprising sales to national retail chains, specialty retailers, dealers, distributors and international distribution partners; and (iii) marketing services, comprising fee-based performance marketing services provided to third-party clients through Sharper Vision Marketing Inc.

 

Revenue Channel

Fiscal Year Ended May 31, 2026

% of Total

Fiscal Year Ended May 31, 2025

% of Total

Hearing enhancement and protection

       

Direct-to-consumer

$ 19,695,815

66.6%

$ 20,571,528

83.2%

Retail and wholesale

9,862,759

33.4%

4,163,573

16.8%

Total segment revenues, net

29,558,574

100.0%

24,735,101

100.0%

         

Hair and skin care

       

Direct-to-consumer

243,381

20.5%

299,562

19.7%

Retail and wholesale

945,615

79.5%

1,222,859

80.3%

Total segment revenues, net

1,188,996

100.0%

1,522,421

100.0%

         

Marketing services

       

Marketing services

100,000

100.0%

         

Consolidated

       

Direct-to-consumer

19,939,196

64.6%

20,871,090

79.5%

Retail and wholesale

10,808,374

35.1%

5,386,432

20.5%

Marketing services

100,000

0.3%

Total revenues, net

$ 30,847,570

100.0%

$ 26,257,522

100.0%

 

 -15- 

Table of Contents

 

In our hearing enhancement and protection segment, the channel mix shifted substantially toward retail and wholesale during fiscal year 2026, which grew 136.9% to $9,862,759 and rose from 16.8% to 33.4% of segment revenues on expanded orders from big box retail chains. Direct-to-consumer revenues declined 4.3%. The shift to retail and wholesale in this segment accounted for primarily all of the $4,590,048 increase in consolidated net revenues.

 

In our hair and skin care segment, the channel mix remained predominantly retail and wholesale at approximately 80% in both periods. Revenues declined in both DTC and retail and wholesale channels primarily due to reduced advertising and marketing spend associated with a planned rebranding and relaunch of the Reviv3 brand scheduled for September 2026. In connection with the relaunch, we expect to onboard additional distributors and retailers in selected domestic and international markets during the second quarter of fiscal year 2027, although the timing and volume of any resulting orders remain uncertain.

 

Because our retail and wholesale channel generates lower gross margins than our DTC channel the increase in this channel’s contribution to consolidated net revenues from approximately 21% for fiscal year 2025 to approximately 35% for fiscal year 2026 was the primary driver of the 170 basis point decline in our consolidated gross profit margin discussed below. We expect that continued growth in the retail and wholesale channel may place additional downward pressure on our consolidated gross margin percentage. However, we believe that the lower sales and marketing, customer acquisition, and certain other operating costs associated with the retail and wholesale channel, as compared to the DTC channel, will help offset the impact of its lower gross margins on overall profitability.

 

Cost of revenues primarily includes the cost of products, freight-in costs, customs duties, and depreciation related to fixed assets that are used in the production and distribution process to bring goods to their saleable condition and location. For the year ended May 31, 2026, the overall cost of revenues increased by $1,851,869 or 24.3%, as compared to the year ended May 31, 2025. Cost of revenues as a percentage of net revenues for the year ended May 31, 2026 was 30.7% as compared to 29.0% for the year ended May 31, 2025. Cost of revenues as a percentage of sales increased, primarily driven by increased sales to big box retail chains in our hearing enhancement and protection segment, which carry tighter margins than our direct-to-consumer channel. The effect of this mix shift was partially offset by lower net customs duties, including refunds of duties received during the year.

 

Gross profit increased by $2,738,179 or 14.7% from $18,641,568 in the year ended May 31, 2025 to $21,379,747 for the year ended May 31, 2026. Gross profit as a percentage of sales for the year ended May 31, 2026 was 69.3%, as compared to 71.0% for the year ended May 31, 2025. The decrease in gross profit margin for the year ended May 31, 2026 was primarily driven by lower margins on material orders from big box retail chains, reflecting the growth of our retail and wholesale channel from approximately 21% of consolidated net revenues in fiscal year 2025 to approximately 35% in fiscal year 2026, partially offset by lower product costs and lower net customs duties, including refunds received.

  

Operating expenses consisted of marketing and selling expenses, compensation and related taxes, research and development, and general and administrative costs. Operating expenses increased by $922,501 or 5.3% from $17,480,203 in the year ended May 31, 2025 to $18,402,704 in the year ended May 31, 2026. Operating expenses as a percentage of net revenues for the year ended May 31, 2026 was 59.7% compared to 66.6% for the year ended May 31, 2025. Included in operating expenses were non-cash stock-based compensation of $785,160 and $1,108,934 in the years ended May 31, 2026 and May 31, 2025, respectively. The primary driver of the increase in operating expenses was a $699,136 increase in sales and marketing expense. Compensation and related taxes also increased year-over-year, reflecting the formalization of executive compensation arrangements during fiscal year 2026. Effective August 2025, the Company entered into employment agreements with its Chief Executive Officer and Chief Financial Officer and Chief Operating Officer, establishing base salaries of $275,000 and $225,000, respectively. Notably, the Chief Executive Officer did not receive a base salary in the prior fiscal year, and the Chief Financial Officer assumed expanded responsibilities during the year and the increases in annual base salaries represent investments in the leadership infrastructure intended to support the Company's continued growth. Further increases in operating expenses related to an absence of approximately $220,000 accounts payable forgiveness recognized in the prior-year that did not recur. Increases in operating expenses were partially offset by lower professional and consulting fees and other operating efficiencies.

 

Income from operations for the year ended May 31, 2026, was $2,977,043 compared to income of $1,161,365 for the year ended May 31, 2025. The increase in income from operations of $1,815,678 or 156.3% was primarily driven by material orders from big box retail chain orders, partially offset by increased operating expenses and by a forgiveness of accounts payable of approximately $220,000 in fiscal 2025 that did not recur in the year ended May 31, 2026.

 

 -16- 

Table of Contents

 

For the year ended May 31, 2026 and 2025, provision for income tax expense was $440,310 and $453,828, respectively.

 

As a result of the above, we reported a net income of $2,699,349 and $854,988 for the years ended May 31, 2026 and May 31, 2025, respectively.

 

Adjusted EBITDA increased by $1,609,078 or 66.2% from $2,430,333 for the year ended May 31, 2025 to $4,039,411 for the year ended May 31, 2026. Adjusted EBITDA as a percentage of revenues, net for the years ended May 31, 2026 and May 31, 2025, was 13.1% and 9.3%, respectively. Adjusted EBITDA increased primarily as a result of material orders from big box retail chains, partially offset by increased operating expenses and by a forgiveness of accounts payable of approximately $220,000 in fiscal 2025, that did not recur in the year ended May 31, 2026.

 

Basic and diluted earnings per share for the year ended May 31, 2026 were approximately $0.40 and $0.33, respectively, compared to $0.13 and $0.10 in the prior year.

 

Results by Segment

 

Hearing Enhancement and Protection. Segment net revenues increased 19.5% to $29,558,574 for the fiscal year ended May 31, 2026 from $24,735,101 for the fiscal year ended May 31, 2025, and represented approximately 96% of consolidated net revenues. The increase was driven entirely by the retail and wholesale channel, as set out in the table above. Segment non-cash operating income increased 54.8% to $5,437,771 from $3,511,895, as the incremental retail and wholesale volume was absorbed with only a 5.3% increase in segment sales and marketing expense, partially offset by the lower gross margin earned on wholesale orders. One customer accounted for 24% of segment net sales and 69% of segment accounts receivable at May 31, 2026.

 

Hair and Skin Care. Segment net revenues decreased 21.9% to $1,188,996 for the fiscal year ended May 31, 2026 from $1,522,421 for the fiscal year ended May 31, 2025, and represented approximately 4% of consolidated net revenues. The decline was broad-based across channels, with retail and wholesale revenues down 22.7% to $945,615 and DTC revenues down 18.8% to $243,381, and reflected reduced advertising and marketing spend associated with a planned rebranding and relaunch of the Reviv3 brand scheduled for September 2026 .   In connection with the relaunch, we expect to onboard additional distributors and retailers in selected domestic and international markets during the second quarter of fiscal 2027, although the timing and volume of any resulting orders remain uncertain.  The segment recorded a segment non-cash operating loss of $47,611, compared with segment non-cash operating income of $157,060 in the prior year, as segment operating expenses of $702,650 exceeded segment gross profit of $655,039. Approximately 45% of segment net sales were to customers outside the United States, principally in Canada and Italy.

 

Marketing Services. This segment, conducted through our wholly owned subsidiary Sharper Vision Marketing Inc., recorded net revenues of $100,000 and segment non-cash operating income of $91,492 for the fiscal year ended May 31, 2026, representing less than 1% of consolidated net revenues. All revenue presented for this segment was earned from third-party clients. Segment gross margin of 95% reflects the limited direct cost of delivering these services, which consisted of $5,000 of subcontractor costs. Because the segment commenced operations during fiscal year 2026 and served a small number of clients, its results are not necessarily indicative of future performance.

 

Liquidity and Capital Resources

 

We are currently engaged in product sales and development and services. Although we earned net income in the fiscal years ended May 31, 2026 and 2025, we have experienced operating losses in prior periods. We expect to continue generating net income and to generate positive cash flow in the fiscal year ending May 31, 2027, although we cannot provide any assurance.

 

Subsequent to May 31, 2026 and prior to the date of this report, we received approximately $910,000 in cash from CBP representing refunds of duties previously paid under the IEEPA, together with interest. Because these amounts were received after the balance sheet date, they are not reflected in cash and cash equivalents at May 31, 2026 or in cash flows from operating activities for the year then ended, and will be presented within operating activities in the statement of cash flows for the fiscal year ending May 31, 2027. No refund claims remain outstanding as of the date of this report. See Note 15 to the consolidated financial statements.

 

 -17- 

Table of Contents

 

We plan to manage expenses relative to expected revenue and may reinvest near-term cash to support revenue growth. In recent years, we have generated sufficient cash to support our operations and required debt payments, and we expect this to continue, although we cannot provide any assurance. Management remains focused on expanding product lines and our customer base to drive revenue. However, future cash demands may exceed historical levels. If needed, we may seek additional capital, although there is no assurance that financing will be available on acceptable terms or at all. Subject to these uncertainties, based on our current cash balances and anticipated operating cash flows, we believe we have sufficient capital and liquidity to fund operations and meet working capital needs for at least one year from the issuance date of the accompanying consolidated financial statements.

 

Cash Flows for the fiscal years ended May 31, 2026 and 2025

 

The following table provides detailed information about our net cash flows: 

 

   

For the Fiscal Year 

Ended May 31,

2026 

   

For the Fiscal Year 

Ended May 31,

2025

 

Cash Flows

               

Net cash (used in)/provided by operating activities

 

$

(9,635

)

 

$

1,928,661

 

Net cash used in investing activities

   

(210,349

)

   

(394,298

)

Net cash used in financing activities

   

(87,830

)

   

(18,385

)

Net (decrease)/increase in cash and cash equivalents

 

$

(307,814

)

 

$

1,515,978

 

 

Operating Activities 

 

Net cash used in operating activities for the year ended May 31, 2026, was $9,635, compared to net cash provided by operating activities of $1,928,661 for the year ended May 31, 2025. While the year-over-year comparison reflects a significant swing, the Company believes this change is primarily attributable to the timing of material orders from a big box retail chain that were fulfilled in the final month of the fiscal year ended May 31, 2026. These transactions, while reflective of strong commercial momentum and expanded retail distribution, resulted in elevated accounts receivable and increased inventory restocking activity at year end, both of which had a temporary adverse effect on operating cash flows. Absent this year-end timing impact, operating cash flows would have been materially positive and broadly consistent with the prior year. Subsequent to May 31, 2026, the outstanding receivables associated with these orders have been substantially collected as of the date of this filing, and the Company does not anticipate this timing difference to have any ongoing impact on its liquidity position. The Company believes its current cash position is sufficient to manage material orders from its wholesale and retail segment and does not anticipate this timing difference to have any ongoing impact on its liquidity position. In addition, subsequent to May 31, 2026 the Company received approximately $910,000 of IEEPA duty refunds, including interest, which were not reflected in operating cash flows for the year ended May 31, 2026 and which will be reflected in operating cash flows in the fiscal year ending May 31, 2027.

 

Investing Activities

 

Net cash used by investing activities decreased to $210,349 for the fiscal year ended May 31, 2026, from $394,298 for the fiscal year ended May 31, 2025, a decrease of $183,949, primarily due to a reduction in purchases of property and equipment during fiscal year 2026. 

 

Financing Activities

 

Net cash flows used in financing activities for the year ended May 31, 2026 was $87,830 compared to $18,385 used in financing activities for the year ended May 31, 2025. The increase in cash used in financing activities related primarily to the repayment of our note payable during the year ended May 31, 2026.

 

As of May 31, 2025, we had a secured Economic Injury Disaster Loan outstanding, administered pursuant to the CARES Act, in the principal amount of $140,229, with a maturity date of May 18, 2050. During the fiscal year ended May 31, 2026, the Company repaid the outstanding balance of the loan in full. As of May 31, 2026, we have no outstanding borrowings.

 

 -18- 

Table of Contents

 

We are dependent on our product sales and services to fund our operations and may require additional capital in the future, such as pursuant to the sale of additional common stock, preferred stock, debt securities or entering into credit agreements or other borrowing arrangements with institutions or private individuals, to maintain operations, which may not be available on favorable terms, or at all, and could require us to sell certain assets or discontinue or curtail our operations. If the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult to obtain, more costly and more dilutive. Our officers and directors have made no written commitments with respect to providing a source of liquidity in the form of cash advances, loans, and/or financial guarantees. We have no present plan or commitment to obtain additional financing, and we anticipate that our existing cash and cash equivalents and cash expected to be provided by operations will be sufficient to meet our working capital requirements for at least the next twelve months. However, if the need arises for additional cash, there can be no assurance that we will be able to raise the capital we need for our operations on favorable terms, or at all. We may not be able to obtain additional capital or generate sufficient revenues to fund our operations. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon our business plans. If we are unsuccessful at raising sufficient funds, for whatever reason, to fund our operations, we may be forced to cease operations. If we fail to raise funds, we expect that we will be required to seek protection from creditors under applicable bankruptcy laws. 

 

Material Cash Requirements

 

Our material cash requirements as of May 31, 2026 consisted principally of the following. Operating lease obligations: undiscounted future lease payments under our Beverly Hills office lease and our American Fork, Utah sublease totaled $583,707, of which $257,647 is payable in fiscal year 2027 (see Note 10 – Commitments and Contingencies to our consolidated financial statements in this report). Inventory purchase commitments: we place purchase orders with a concentrated group of third-party manufacturers, and as of May 31, 2026 we had outstanding, non-cancellable inventory purchase commitments of approximately $1,080,000, substantially all of which are expected to be settled within twelve months. Accrued executive compensation: accrued but unpaid annual performance bonuses of $156,713 for our named executive officers are included in other current liabilities at May 31, 2026 and are expected to be paid during fiscal year 2027. Income taxes: our income tax liability of $688,150 at May 31, 2026 is expected to be settled within twelve months. We expect to fund these requirements from existing cash and cash equivalents, from the collection of accounts receivable and from cash generated by operations. As of August 14, 2026, we had approximately $7,420,000 in cash and cash equivalents.

 

Related Party Advances

 

Intrepid Global Advisors, Inc. (“Intrepid”), of which our Chief Executive Officer and Chairman is the managing director, has from time to time provided short-term advances to the Company for working capital purposes. During the fiscal year ended May 31, 2026, advances from Intrepid totaled $5,939,172 and repayments to Intrepid totaled $5,886,773, and at May 31, 2026 the Company had a payable to Intrepid of $52,177. During the fiscal year ended May 31, 2025, advances totaled $6,950,210 and repayments totaled $6,962,230. These advances are not evidenced by a written agreement, are uncommitted, are non-interest bearing and are repayable on demand. Although these advances have not resulted in a material outstanding obligation at either balance sheet date, we rely on this uncommitted arrangement to manage intra-period working capital timing, and its discontinuation could require us to seek alternative sources of short-term liquidity on less favorable terms or to alter the timing of inventory purchases. See Note 11 – Related Party Transactions to our consolidated financial statements in this report and Item 13 of this report.

 

Off-Balance Sheet Arrangements

 

As of May 31, 2026, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results or operations, liquidity, capital expenditures or capital resources that is material to investors.

  

Critical Accounting Policies and Estimates

 

Critical accounting policies and practices are those that are both most important to the portrayal of the Company’s financial condition and results, and require management’s most difficult, subjective, or complex judgments, often as a result of the need to make estimates.

 

 -19- 

Table of Contents

 

Accounts receivable and allowance for credit losses

 

The Company has a policy of providing an allowance for credit losses based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to provision for credit losses and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. 

 

Revenue recognition

 

We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers. Revenue is recognized when control of the product is transferred to the customer, typically upon shipment. In determining the transaction price, we consider discounts, promotional incentives, and expected returns. These estimates require judgment based on historical experience and current market conditions. Changes in customer behavior or promotional strategies could impact the timing and amount of revenue recognized. 

 

Goodwill

 

Goodwill represents the excess of the consideration paid over the fair value of net assets acquired in a business combination. We evaluate goodwill for impairment at least annually during the fourth quarter, or more frequently if circumstances or events suggest potential impairment. Throughout the year, we monitor for indicators that might trigger an interim impairment review. Our testing may begin with a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If a quantitative test is performed, fair value is estimated based on the amount a market participant would pay in a hypothetical sale of the reporting unit. When the fair value exceeds the carrying value, goodwill is considered to be not impaired. If the carrying value exceeds fair value, an impairment charge is recorded for the amount of the excess, limited to the total carrying amount of goodwill. 

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

As a smaller reporting company, we are not required to provide the information required by this Item 7A. 

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 

The financial statements of the Company and the related report of the Company’s independent registered public accounting firm thereon have been filed under Item 15 hereof.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Principal Executive Officer, and Chief Financial Officer (“CFO”) and Principal Financial and Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure. We conducted an evaluation, under the supervision and with the participation of our CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures as of May 31, 2026. Based on this evaluation of disclosure controls and procedures as of May 31, 2026, our CEO and CFO concluded that our disclosure controls and procedures were effective.

 

 -20- 

Table of Contents

 

Management’s Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) or 15d-15(f). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management, including our CEO and CFO, assessed the effectiveness of our internal control over financial reporting as of May 31, 2026 using criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework issued in 2013. Based on the assessment, our management has concluded that as of May 31, 2026, our internal control over financial reporting was effective based on those criteria.  

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to the rules of the SEC that permit us to provide only management’s report in this annual report.

 

Changes in Internal Controls

 

There has been no change in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) or 15d-15(d) under the Exchange Act that occurred during the fiscal quarter ended May 31, 2026 that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION.

 

Rule 10b5-1 Trading Plans

 

During the quarter ended May 31, 2026, none of the Company’s directors or executive officers adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K).

 

2026 Annual Meeting of Stockholders

 

The Company’s 2026 Annual Meeting of Stockholders is scheduled to be held on December 16, 2026. Stockholders of record as of October 21, 2026 will be entitled to receive notice of, and vote at, the 2026 Annual Meeting of Stockholders.

 

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.

 

Not applicable.

 

 -21- 

Table of Contents

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

 

Information about our Directors and Executive Officers

 

The Board is divided into three classes: Class I, Class II and Class III. Each director will serve for a term ending on the date of the third annual meeting following the annual meeting at which such director was elected and such director’s successor is elected and qualified, or until such director’s earlier death, resignation, disqualification or removal from office.

 

The names, ages and positions of our present directors and executive officers as of August 14, 2026 are set forth below:

 

NAME

 

AGE

 

DIRECTOR CLASS

 

POSITION

Jeff Toghraie

   

59

   

Class III director, with a term expiring at the 2027 annual meeting of stockholders

 

Chief Executive Officer and Chairman of the Board

                 

Jeff Brown

   

44

   

Class III director, with a term expiring at the 2027 annual meeting of stockholders

 

Chief Financial Officer, Chief Operating Officer, and Director

                 

Manu Ohri

   

70

   

Class II director, with a term expiring at the 2028 annual meeting of stockholders

 

Director

                 

Thomas Penna

   

64

   

Class II director, with a term expiring at the 2028 annual meeting of stockholders

 

Director

                 

Nancy Hundt

   

58

   

Class I director, with a term expiring at the 2026 annual meeting of stockholders

 

Director

 

Jeff Toghraie – Chief Executive Officer and Chairman of the Board of Directors

 

Jeff Toghraie has served as our Chief Executive Officer and as a member of and chairman of our Board since June 2015. Mr. Toghraie joined Intrepid Global Advisors, which provides advisory services, in October 2010 and is a managing director and principal of that firm. Mr. Toghraie has been involved with various privately held development stage companies as a director and/or in advisory positions for more than 20 years.

 

Mr. Toghraie brings more than 20 years of experience in our industry. His background working with development stage companies and extensive business and operational experience provide us with the expertise to implement complex and innovative strategies and makes him uniquely suited to serve on our Board.

  

Jeff Brown – Chief Financial Officer, Chief Operating Officer, and Director

 

Jeff Brown has served as our Chief Operating Officer since March 2017, as our Chief Financial Officer since May 2024, and as a member of our Board since February 2024. Mr. Brown also serves as the co-owner, Chairman of the board of directors and Chief Financial Officer of BZ Capital Strategies, which provides consulting services and serves as an investment vehicle. Previously, from July 2016 to March 2017, Mr. Brown held consulting positions at Polar Solar Inc., a company responsible for making commercial solar panels available to the residential market, and Mind Fitness Lab, a technology company that developed and distributed mobile applications for mental health professionals. From June 2012 until July 2015, he was the President of RNA Pro, a company that distributed agricultural supplements. He holds a master’s degree in business administration from Pepperdine University and a bachelor’s degree in political science from University of California, Irvine.

 

 -22- 

Table of Contents

 

Mr. Brown brings over 15 years of operational experience in our industry. His experience, deep industry knowledge, and comprehensive understanding of the execution and operational needs of a fast-growing business allow him to provide targeted and forward-thinking insight to our Board. 

 

Thomas Penna – Director

 

Thomas Penna, has been a member of our Board since January 2026. Mr. Penna serves as the Chair of our Nominating and Corporate Governance Committee. Mr. Penna is a senior business operator and entrepreneur with extensive experience leading service, beauty, staffing, and multi-location businesses. Mr. Penna currently serves as Chief Executive Officer and Managing Partner of LATT Holdings, a holding company managing investment interests following the sale of operating beauty businesses, a position he has held since September 2018. Concurrently, from January 2022 to June 2026, Mr. Penna served as Head of Operations for Ace High Casino Rentals, where he managed high-volume operational requirements, client relations, and workforce coordination. Previously, from March 2014 to November 2018, Mr. Penna served as Chief Executive Officer of Penko Beauty, a beauty-industry enterprise, where he led executive management, business strategy, and commercial relationships. Prior to that, Mr. Penna was a Partner at Salon Gallery and Suites from February 2014 to September 2018, overseeing growth and operations until its successful sale. From November 1996 to September 2018, Mr. Penna served as Chief Executive Officer of Salon Gallery Full Service Hair Salon, where he built and managed teams in a service-intensive environment. Mr Penna previously served on the Tustin Police Department Advisory Board from 2015 to 2016.

 

Mr. Penna’s extensive experience in the hair care and salon industries and deep knowledge of our industry make him well qualified to serve on our Board.

  

Manu Ohri – Director

 

Manu Ohri has served as a member of our Board of Directors since February 2024. He currently serves as chief financial officer of ToughBuilt Industries, Inc., a company that designs and distributes tools and accessories for the home improvement and construction industries, a position he has held since July 2024. Mr. Ohri previously served as chief financial officer and a member of the Board of Directors of ToughBuilt Industries, Inc. from January 2017 through June 2019. Prior to that, from December 2015 through December 2016, he served as an independent business advisor and consultant to the company. From February 2022 through June 2024, Mr. Ohri served as chief financial officer of GT Biopharma, Inc., a clinical-stage biopharmaceutical company.

 

From January 2010 through December 2016, Mr. Ohri served as a management consultant with Anarjay Concepts, Inc., providing management consulting and business advisory services to privately held and publicly traded companies. Earlier in his career, he gained more than seven years of professional experience with Deloitte & Touche LLP and PricewaterhouseCoopers LLP. Mr. Ohri is a Certified Public Accountant and a Chartered Global Management Accountant. He holds a Master of Business Administration degree from the University of Detroit and a Bachelor of Commerce Honors degree from the University of Delhi. He previously served as an independent director of Shengda Network Technology, Inc.

 

Mr. Ohri brings more than 35 years of experience in corporate finance, accounting and financial reporting, corporate governance, investor relations, mergers and acquisitions, strategic planning, and business advisory services. His experience includes working extensively with boards of directors and financial institutions and advising companies regarding U.S. and international financial accounting and reporting standards. He also has significant experience in team building, project management, and strategic business development.

 

Mr. Ohri's extensive financial, accounting, governance, and executive management experience, together with his broad exposure to multiple industries and both public and private companies, provides the Board with valuable financial expertise, strategic perspective, and diverse industry knowledge.

 

 -23- 

Table of Contents

 

Nancy Hundt – Director

 

Nancy Hundt has been a member of our Board since May 2015. She has served as chief operating officer of Academy Optical, Inc., a prescription eyewear retailer, since February 2019. Prior to that, from September 2009 to February 2019, Ms. Hundt served as director of operations for Academy Optical, Inc. Additionally, Ms. Hundt has served as a representative of the American Board of Opticianry, an optical industry retail group, since October 1991.

  

Ms. Hundt brings to our Board more than 30 years of strategic planning and advising experience in the retail industry. She has a diverse background as a consultant and retail sales expert, and she has a strong understanding of our business strategy.

 

Family Relationships

 

There are no family relationships among any of our directors or executive officers.

 

Involvement in Certain Legal Proceedings

 

To the best of our knowledge, none of our directors or executive officers were involved in any legal proceedings described in Item 401(f) of Regulation S-K in the past 10 years.

 

Board Committees

 

Our Board currently consists of five directors. Our Board has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. Each member of each standing committee of our Board qualifies as an independent director in accordance with the applicable rules of the SEC and NYSE American. Each standing committee operates pursuant to a written charter adopted by our Board, each of which is posted on the Investors section of our website at www.goaxil.com. Our Board may establish other committees as it deems necessary or appropriate from time to time.

 

The following table provides current committee membership for each of the committees of the Board as of August 14, 2026:

 

Name(1)

 

Audit

 

Compensation

 

Nominating and CorporateGovernance

Jeff Toghraie

         

Jeff Brown

         

Thomas Penna

X

 

X

 

  X*

Nancy Hundt

X

 

   X*

 

X

Manu Ohri+

  X*

 

X

 

X

 

* Committee chairperson.

 

+ Audit committee financial expert.

 

(1)On January 15, 2026, Peter Dunne resigned from the Board, including from all committee positions. In addition, on January 15, 2026, Thomas Penna was appointed to the Board and to serve as a member of the Audit Committee and Compensation Committee and as chair of the Nominating and Corporate Governance Committee.

 

 -24- 

Table of Contents

 

Code of Business Conduct and Ethics

 

Our Board has adopted a Code of Business Conduct and Ethics, which applies to all of our directors, employees, and officers (including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions). The full text of our Code of Business Conduct and Ethics is posted on the Investors section of our website at www.goaxil.com. Any substantive amendment of the Code of Business Conduct and Ethics, and any waiver of the Code of Business Conduct and Ethics for executive officers or directors, will be made only after approval by the Board or, for any amendments, the Audit Committee or the Nominating and Corporate Governance Committee of the Board, and will be disclosed on our website. The rules of the NYSE American require any waiver of the Code of Business Conduct and Ethics for executive officers or directors be approved by the Board. In addition, any such amendment or waiver will be disclosed within four days on a Form 8-K filed with the SEC if then required by applicable rules and regulations, including the rules of the NYSE American, which currently require a Form 8-K to be filed disclosing any waiver of the Code of Business Conduct and Ethics for directors and officers.

 

Delinquent Section 16(a) Reports

 

Section 16(a) of the Exchange Act requires our officers, directors and persons who own more than 10% of our common stock to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities. To our knowledge, based on solely a review of these reports filed with the SEC, we believe that all Section 16 filing requirements applicable to our executive officers, directors and greater than 10% stockholders were complied with during the fiscal year ended May 31, 2026 and through the date of this annual report, except for a Form 4 filed by Manu Ohri on March 4, 2026, reporting the annual grant of restricted stock pursuant to the Company’s non-employee director compensation program on January 15, 2026. 

 

Insider Trading Policy

 

The Company’s Insider Trading Policy provides guidelines to officers, directors, employees and agents of the Company with respect to transactions in the Company’s securities. The Company has adopted the Insider Trading Policy and the procedures set forth therein to help prevent insider trading and to assist the Company’s officers, directors, employees and agents in complying with their obligations under the federal securities laws. The Insider Trading Policy applies to all transactions in the Company’s securities, as well as transactions in securities about a company with which the Company does business, such as the Company’s vendors, customers, suppliers and distributors, in which the Company has significant investments, or that is involved in a potential transaction or business relationship with Company. Under the Insider Trading Policy, the Company’s directors, officers and employees are prohibited from engaging in any short sale transactions; investing in Company-based derivative securities, including options, warrants, and similar rights whose value is derived from the value of any of our equity securities, including, without limitation, trading in Company-based put or call option contracts; engaging in hedging or monetization transactions with respect to the Company’s securities, including through the use of financial instruments such as prepaid variable forwards, equity swaps, collars and exchange funds; and, unless prior written approval has been granted by the Chief Executive Officer, holding our securities in a margin account or otherwise pledging our securities as collateral. For additional information, see the Insider Trading Policy, which is included in the exhibit index to this Form 10-K and posted on the investor relations section of our website at www.goaxil.com.

 

It is also the policy of the Company that the Company will not engage in transactions in Company securities, or adopt any securities repurchase plans, while in possession of material non-public information relating to the Company or its securities other than in compliance with applicable law.

 

 -25- 

Table of Contents

 

ITEM 11. EXECUTIVE COMPENSATION.  

 

The following table sets forth the compensation paid by us for the last two fiscal years ended May 31, 2026, and 2025, to our named executive officers (each, an “NEO”), who, for the fiscal year ended May 31, 2026, were Jeff Toghraie, our Chief Executive Officer and Chairman (Principal Executive Officer), and Jeff Brown, our Chief Operating Officer and Chief Financial Officer and Director.

 

Summary Compensation Table

 

Name and Principal Position

 

Year

 

Salary($)
(1)

 

Bonus($)

 

StockAwards
($)

 

OptionAwards
($)
(3)

 

Non-EquityIncentive Plan
Compensation
($)

 

NonqualifiedDeferred
Compensation
Earnings ($)

 

All Other Compensation ($)

 

Total ($)

Jeff Toghraie

Chief Executive Officer and Chairman

   

2026

     

206,250

     

86,192

(2) 

   

     

     

     

     

291,100

(5) 

   

583,542

 
     

2025

     

     

     

     

1,403,500

(4)  

   

     

     

227,100

(5)  

   

1,630,600

 

Jeff Brown

Chief Operating Officer, Chief Financial Officer and Director

   

2026

     

204,750

     

70,521

(2) 

   

     

     

     

     

265,000

(6) 

   

540,271

 
     

2025

     

144,000

     

     

     

1,002,500

(4)  

   

     

     

120,000

(6)  

   

1,266,500

 

 

(1)

Represents base salary earned during the applicable fiscal year. Neither of the NEOs elected to receive any portion of his base salary in shares of the Company’s common stock.

(2)

Represents annual performance bonuses earned for the fiscal year ended May 31, 2026 and paid in July 2026. The bonuses had not been paid as of May 31, 2026. Under their respective Agreements (as defined below), each NEO is eligible for an annual bonus with a target bonus opportunity of not less than 40% of base salary. The actual bonus amounts are determined by the Board based on performance and other factors. Neither of the NEOs elected to receive any portion of his annual bonus in shares of the Company’s common stock.

(3)

The value of option awards in this table represents the fair value of such awards granted or modified during the fiscal year, as computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. The assumptions used to determine the valuation of the awards are discussed in Note 9—Stockholders’ Equity to our consolidated financial statements included herein.

(4)

On October 8, 2024, the Compensation Committee of the Board approved the grant of 350,000 options to purchase the Company’s common stock to Mr. Toghraie and 250,000 options to purchase the Company’s common stock to Mr. Brown. The options were granted effective October 14, 2024 and have an exercise price of $4.01 per share, a term of 10 years from the grant date, and vest and become exercisable in 48 equal monthly installments over the four-year period beginning October 31, 2024, subject to the executive’s continued service with the Company.

(5)

Consists of consulting fees paid by the Company to Intrepid Global Advisors, Inc., of which Mr. Toghraie is the managing director.

(6)

Consists of consulting fees paid by the Company to BZ Capital Strategies, of which Mr. Brown is the co-owner, Chairman and Chief Financial Officer.

 

 -26- 

Table of Contents

 

On August 18, 2025, the Company entered into employment agreements (each, an “Agreement” and, collectively, the “Agreements”) with each of Jeff Toghraie, the Company’s Chief Executive Officer and Chairman, and Jeff Brown, the Company’s Chief Financial Officer, Chief Operating Officer and Director in order to memorialize the terms and conditions of each NEO’s continued employment in his respective position. Each Agreement will remain in effect until the NEO’s employment terminates for any reason in accordance with the terms of the Agreement.

 

At the time that the Agreements were entered into, the Compensation Committee approved an annual base salary for Mr. Toghraie of $275,000, and Mr. Brown’s annual base salary was adjusted to $225,000. Each NEO is eligible for an annual bonus with a target bonus opportunity of not less than 40% of his respective base salary. Each NEO may elect to receive his salary and/or the annual bonus in shares of the Company’s common stock. Each NEO is eligible to participate in long-term incentive programs of the Company, as may be made available at the discretion of the Board. Additionally, each NEO is eligible for paid vacation in accordance with the Company’s policy and is entitled to participate in the employee benefit plans offered by the Company to its senior executives. In the event of a Change of Control (as defined in the Agreements), Mr. Toghraie and Mr. Brown will receive 500,000 and 175,000 fully vested shares of the Company’s common stock (subject to adjustment), respectively. In the event the Company terminates the NEO’s employment without Cause (as defined in the Agreement) or if the NEO resigns for Good Reason (as defined in the Agreement), the NEO will receive accrued compensation and a severance payment equal to a multiple (three times, for Mr. Toghraie, or two times, for Mr. Brown) of the sum of his base salary plus the greater of the average annual bonus paid for the prior three fiscal years or his target annual bonus, subject to a release of claims. Upon termination for Cause, resignation without Good Reason, death, or Disability (as defined in the Agreements), the NEO will receive only his accrued compensation. The Agreements also contain customary provisions regarding confidentiality and assignment of work product, as well as provisions relating to indemnification and D&O insurance coverage.

 

 -27- 

Table of Contents

 

Prior to August 18, 2025, Jeff Toghraie, the Company’s Chief Executive Officer and Chairman, and Jeff Brown, the Company’s Chief Financial Officer and Chief Operating Officer and a director, did not have formal employment agreements with the Company in place. Mr. Toghraie was entitled to an annual performance bonus, health benefits and equity awards at the discretion of the Board. Mr. Brown received a base salary of $144,000 per year and was entitled to annual performance bonus, paid vacation, optional health benefits and equity awards at the discretion of the Board.

 

As of May 31, 2026, the Company maintained the Agreements described above, which provide for severance and Change of Control compensation for each NEO as described above. In addition, under the Amended and Restated 2022 Equity Incentive Plan (as amended and restated, the “Plan”), upon the occurrence of a change of control (as defined in the Plan), unless otherwise provided in an award agreement: (i) all outstanding stock options will become immediately exercisable in full; (ii) all outstanding performance shares will vest in full as if the applicable performance conditions were achieved in full, subject to certain adjustments, and will be paid out as soon as practicable; and (iii) all restricted stock will immediately vest in full. Subject to the Plan’s terms, the Compensation Committee or the Board has full power and authority to determine whether, to what extent and under what circumstances any outstanding award will be terminated, canceled, forfeited or suspended. Awards to that are subject to any restriction or have not been earned or exercised in full by the recipient will be terminated and canceled if such recipient is terminated for cause.

 

As of May 31, 2026, we did not have any retirement, pension, or profit sharing plans for the benefit of our executive officers and directors.

 

Outstanding Equity Awards at Fiscal Year-End

 

The following table sets forth certain information regarding outstanding equity awards held by the NEOs as of May 31, 2026:

 

         

Option Awards

Name

 

Grant Date

   

Number of securities
underlying
unexercised
options
(#) exercisable

     

Number of securities
underlying
unexercised options
(#) unexercisable

     

Option exercise price
($)

   

Option expiration date

Jeff Toghraie

 

5/10/2022

   

155,000

     

     

1.80

   

4/20/2032

   

10/14/2024

   

145,833

     

204,167

(1) 

   

4.01

   

10/31/2034

Jeff Brown

 

5/10/2022

   

110,000

     

     

1.80

   

4/20/2032

   

10/14/2024

   

104,167

     

145,833

(1) 

   

4.01

   

10/31/2034

 

 

(1)

These options vest and become exercisable in 48 equal monthly installments beginning on October 31, 2024.

 

Policies and Practices Related to the Grant of Certain Equity Awards

 

We do not schedule the grant of stock options or other equity awards in anticipation of the disclosure of material nonpublic information, and we do not schedule the disclosure of material nonpublic information based on the timing of grants of stock options or other equity awards. We have not adopted any formal policy that would require the Compensation Committee or the Board to grant, or to avoid granting, stock options or other equity awards to our named executive officers or other employees at certain times.

 

 -28- 

Table of Contents

 

Clawback Policy

 

Our Board has adopted a Clawback Policy to comply with SEC and NYSE American rules for the clawback of certain executive compensation in the event that we are required to prepare a restatement of our financial statements due to material noncompliance with any financial reporting requirement under the securities laws. In the event of such a restatement, the Clawback Policy provides that the Board or, if so designated by the Board, the Compensation Committee, will require reimbursement or forfeiture of the amount (if any) of incentive compensation received by the executive officer that exceeds the amount of incentive compensation that otherwise would have been received had it been determined based on the restated amounts, computed without regard to any taxes paid, deemed to have been received by any covered executive officer during the three completed fiscal years immediately preceding the date on which the Company is required to prepare the accounting restatement. Covered executive officers include both current and former executive officers, and incentive compensation includes any compensation that is granted, earned, or vested based (in whole or in part) on the attainment of one or more financial reporting measures. Financial reporting measures are those that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures. The Clawback Policy is effective with respect to covered incentive compensation awarded, granted to or received by a covered executive officer on or after February 14, 2024 and any incentive compensation that was outstanding as of such date.

 

Director Compensation

 

The following table sets forth the compensation paid by us to our non-employee directors for the fiscal year ended May 31, 2026, which consisted of the value of restricted stock awards of 5,000 shares of the Company’s common stock granted to our non-employee directors during that fiscal year. We did not pay any other compensation to our non-employee directors during the fiscal year ended May 31, 2026. Mr. Toghraie and Mr. Brown do not receive any separate compensation for their services as director.

 

Name

 

Fees Earned or Paid in Cash

($)

 

Stock Awards

($)(2)

 

All Other Compensation
($)

 

Total

($)

 

Thomas Penna

 

 

39,850

 

 

39,850

 

Nancy Hundt

 

 

39,850

 

 

39,850

 

Manu Ohri

 

 

39,850

 

 

39,850

 

Peter Dunne(1)

 

 

 

 

 

 

(1)

Peter Dunne resigned from the Board effective January 15, 2026.

(2)

Reflects the grant date fair value of 5,000 shares of restricted common stock granted to each of our non-employee directors on January 15, 2026, which vest on January 15, 2027, except as otherwise provided in the applicable award notice. The value of stock awards in this table represents the fair value of such awards granted or modified during the fiscal year, as computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. The assumptions used to determine the valuation of the awards are discussed in Note 9—Stockholders’ Equity to our consolidated financial statements included herein. As of May 31, 2026, each of the non-employee directors serving on that date held a total of 5,000 unvested shares of the Company’s restricted common stock. Mr. Dunne did not receive any shares of restricted common stock on January 15, 2026 and did not hold any unvested shares of restricted common stock on May 31, 2026.

 

 -29- 

Table of Contents

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

 

The following table sets forth the ownership, as of August 14, 2026, of our common stock by each person known by us to be the beneficial owner of more than five percent (5%) of our outstanding common stock, our directors, our named executive officers, and our directors and current executive officers as a group. Except as indicated by the footnotes below, we believe, based on the information furnished to us, that the persons named in the table below have sole voting and investment power with respect to all shares of common stock shown that they beneficially own, subject to community property laws where applicable. The information does not necessarily indicate beneficial ownership for any other purpose.

 

Shares of our common stock that are subject to options currently exercisable or exercisable within 60 days of August 14, 2026 and to outstanding shares of convertible preferred stock are deemed to be outstanding for computing the percentage ownership of the person holding these options or shares of preferred stock and the percentage ownership of any group in which the holder is a member, but are not deemed outstanding for computing the percentage of any other person. The number of shares held and percentage included in the table does not take into account the beneficial ownership limitations included in the Series A Preferred Stock.

 

We have based our calculation of the percentage of beneficial ownership on 6,822,681 shares of our common stock outstanding on August 14, 2026.

 

Unless otherwise noted below, the address for each of the stockholders in the table below is c/o Axil Brands, Inc., 9150 Wilshire Boulevard, Suite 245, Beverly Hills, California 90212.

 

Name of Beneficial Owner

 

Number of Shares Beneficially Owned

 

Percent

5% Stockholders:

       

Jeff Toghraie, Chief Executive Officer and Chairman(1)

 

3,624,538

 

45.7%

Don Frank Nathaniel Vasquez(2)

 

1,276,251

 

18.7%

Jeff Brown, Chief Financial Officer, Chief Operating Officer and Director(3)

 

410,143

 

5.8%

         

Named Executive Officers and Directors (not otherwise included above):

       

Thomas Penna, Director(4)

 

23,000

 

*

Nancy Hundt, Director(4)

 

17,273

 

*

Manu Ohri, Director(6)

 

25,001

 

*

       

*

All Current Executive Officers and Directors as a Group (5 persons)(7)

 

4,099,955

 

50.1%

 

* Represents beneficial ownership of less than 1% of the outstanding common stock.

 

 -30- 

Table of Contents

 

 

(1)

Based on a Schedule 13D/A filed with the SEC on April 2, 2025 by Jeff Toghraie, Intrepid Global Advisors, Inc. (“Intrepid”), of which Mr. Toghraie is the managing director, and Don Frank Nathaniel Vasquez, and a Form 4 filed by Mr. Toghraie with the SEC on October 15, 2024. Mr. Toghraie may be deemed to beneficially own, in the aggregate, 3,624,538 shares of common stock, consisting of 1,246,700 shares of common stock held directly by Intrepid, over which Mr. Toghraie and Intrepid have shared voting and dispositive power; 1,275,000 shares of common stock held directly by Don Frank Nathaniel Vasquez, over which Mr. Toghraie and Intrepid have shared voting power with Mr. Vasquez, pursuant to a Voting Agreement and Irrevocable Proxy between Mr. Vasquez and Intrepid, pursuant to which Intrepid is authorized to vote and exercise all voting rights with respect to such shares; 330,000 shares of common stock issuable upon the exercise of options held by Mr. Toghraie that are exercisable within 60 days of August 14, 2026; and 772,838 shares of common stock that may be acquired upon the conversion of Series A Preferred Stock held directly by Intrepid, over which Mr. Toghraie and Intrepid have shared dispositive power. The terms of the Voting Agreement and Irrevocable Proxy will expire on the earlier of: (i) October 17, 2026, (ii) such date and time designated by Intrepid in a written notice to Mr. Vasquez or (iii) the written agreement of Intrepid and Mr. Vasquez to terminate such agreement. The Series A Preferred Stock is convertible into shares of common stock on a twenty-for-one basis, at the option of the holder at any time; provided, that the holder may not convert that number of shares of Series A Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the Company’s common stock, as determined in accordance with Sections 13(d) and (g) of the Exchange Act and the rules and regulations thereunder. The principal business office of Intrepid is located at 325 N. Maple Drive, #5114, Beverly Hills, California 90210.

 

 

(2)

Based on a Schedule 13D/A filed with the SEC on April 2, 2025 by Jeff Toghraie, Intrepid, and Don Frank Nathaniel Vasquez, Mr. Vasquez has sole voting power over 1,251 shares of common stock, sole dispositive power over 1,276,251 shares of common stock and shared voting power over 1,275,000 shares of common stock with Intrepid and Mr. Toghraie, pursuant to a Voting Agreement and Irrevocable Proxy between Mr. Vasquez and Intrepid, pursuant to which Intrepid is authorized to vote and exercise all voting rights with respect to such shares. The terms of the Voting Agreement and Irrevocable Proxy will expire on the earlier of: (i) October 17, 2026, (ii) such date and time designated by Intrepid in a written notice to Mr. Vasquez or (iii) the written agreement of Intrepid and Mr. Vasquez to terminate such agreement. The principal business address of Mr. Vasquez is 4700 Summerville Lane, Prosper, Texas 75078.

 

 

(3)

Based on a Schedule 13D/A filed with the SEC on November 3, 2025 by Jeff Brown and BZ Capital Strategies, of which Mr. Brown is the co-owner, Chairman and Chief Financial Officer, and a Form 4 filed by Mr. Brown with the SEC on November 3, 2025, Mr. Brown may be deemed to beneficially own, in the aggregate, 410,143 shares of common stock consisting of: (i) 15,143 shares of common stock held directly by Mr. Brown; (ii) 235,000 shares of common stock issuable upon the exercise of options held by Mr. Brown that are exercisable within 60 days of August 14, 2026; (iii) 145,000 shares of common stock held directly by BZ Capital Strategies; and (iv) 15,000 shares of common stock that may be acquired upon conversion of Series A Preferred Stock held directly by BZ Capital Strategies. The principal business address of BZ Capital Strategies is 200 N. Swall Drive, Unit 513, Beverly Hills, California 90211.

 

 

(4)

Includes 5,000 shares of unvested restricted stock, which will vest on January 15, 2027.

 

 

(6)

 

Includes 5,000 shares of unvested restricted stock, which will vest on January 15, 2027, and 10,000 shares held by Anarjay Concepts Inc., of which Mr. Ohri is the principal.

 

 

(7)

Includes 15,000 shares of unvested restricted common stock, options to purchase 565,000 shares of common stock that are exercisable within 60 days of August 14, 2026, and 787,838 shares of common stock that may be acquired upon the conversion of Series A Preferred Stock. This group includes all current directors and executive officers as of August 14, 2026.

 

Equity Compensation Plan Information 

 

The following table sets forth equity compensation plan information as of May 31, 2026:

 

 -31- 

Table of Contents

 

Plan category

 

Number of securities to be issued upon
exercise of
outstanding options,
warrants and rights
(a)

 

Weighted-average exercise price of
outstanding options,
warrants and rights

(b)

 

Number of securities remaining available
for future issuance
under equity
compensation plans
(excluding securities
reflected in column
(a)(c)

Equity compensation plans approved by security holders(1)

   

907,750

   

$

3.49

     

1,097,421

 

Equity compensation plans not approved by security holders

   

-

   

$

-

     

-

 

Total

   

907,750

   

$

3.49

     

1,097,421

 

 

(1)

Represents shares of common stock to be issued upon exercise of outstanding options to purchase common stock granted pursuant to the Plan as of May 31, 2026. The Plan provides for an annual increase on April 1 of each calendar year, beginning in 2022 and ending in 2031, subject to the approval of the Plan administrator on or prior to such date. Such increase may be equal to the lesser of (i) 4% of the total number of shares of the Company’s common stock outstanding on May 31 of the immediately preceding fiscal year and (ii) such smaller number of shares as determined by the Plan’s administrator. The number of shares authorized for issuance under the Plan will not change unless the Plan’s administrator affirmatively approves an increase in the number of shares authorized for issuance prior to April 1 of the applicable year. All shares available for future issuance are under the Plan.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

 

Director Independence

 

We are subject to the corporate governance requirements of the NYSE American and apply the rules of the SEC and the NYSE American to evaluate the independence of our directors. The Board has determined that, of the five Board members, each of Mr. Penna, Ms. Hundt, and Mr. Ohri qualifies as independent under the NYSE American listing standards. Peter Dunne, who served on the Board during fiscal year 2026 also satisfied the independence criteria in the applicable NYSE American listing standards. Accordingly, our Board is currently, and was during fiscal year 2026, comprised of a majority of directors who qualify as independent directors under the rules adopted by the SEC and NYSE American, and all Board committee members are currently, and were during fiscal year 2026, independent for the purposes of the committees on which they serve or served. In making such independence determinations, our Board considered the relationships that each non-employee director has with us and all other facts and circumstances that our Board deemed relevant in determining their independence.

 

Related Party Transactions 

 

The following is a description of transactions or series of transactions since June 1, 2024, to which we were or will be a party, in which:

 

 

·

the amount involved in the transaction exceeds the lesser of (i) $120,000 or (ii) 1% of the average of our total assets at year end for the last two completed fiscal years; and

 

 

·

in which any of our executive officers, directors, director nominees or holders of 5% or more of any class of our voting capital stock, or any immediate family member of any of the foregoing, had or will have a direct or indirect material interest.

 

 -32- 

Table of Contents

 

The Company reviews and approves all related party transactions.

 

The Company’s Chairman and Chief Executive Officer, Jeff Toghraie, is the managing director of Intrepid Global Advisors, Inc. (“Intrepid”). Intrepid has, from time to time, provided advances to the Company for working capital purposes and is paid consulting fees throughout the year. The Company recorded and paid $291,100 and $227,100 in consulting fees for the years ended May 31, 2026 and 2025, respectively. At May 31, 2026, the Company had a payable to Intrepid of $52,177 and as of May 31, 2025 an amount receivable from Intrepid of $222 relating to an overpayment. During the year ended May 31, 2026, advances from Intrepid were $5,939,172 and repayments to Intrepid were $5,886,773. During the year ended May 31, 2025, advances from Intrepid were $6,950,210 and repayments to Intrepid were $6,962,230. Advances made from Intrepid are short-term in nature, non-interest bearing and relate to credit utilization by the Company, primarily in connection with the Company’s marketing and advertising campaigns.

 

The Company’s Board Member, Chief Financial Officer, and Chief Operating Officer is the co-owner, Chairman and Chief Financial Officer of, and has a controlling interest in, BZ Capital Strategies. The Company recorded consulting fees to BZ Capital Strategies totaling $265,000 and $120,000 for the years ended May 31, 2026 and 2025, respectively. As of May 31, 2026 and 2025, the Company had a payable to BZ Capital Strategies of $100,000 and $0, respectively.

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

  

Pursuant to the Audit Committee Charter, the Audit Committee is required to pre-approve all auditing services and permitted non-audit services to be performed for us by our independent registered public accounting firm, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act that are approved by the Audit Committee prior to the completion of the audit). For fiscal years 2026 and 2025, all services performed by our independent auditors were pre-approved by the Audit Committee.

 

Fees

 

The following table sets forth the fees paid to Salberg & Company, P.A., for the fiscal years ended May 31, 2026 and 2025: 

 

   

Fiscal Year Ended
May 31,
2026

 

Fiscal Year Ended
May 31,
2025

Audit fees (1)

 

$

137,200

   

$

132,800

 

Audit related fees (2)

   

     

2,500

 

Tax fees

   

     

 

All other fees

   

     

 

Total

 

$

137,200

   

$

135,300

 

 

 

(1)

These fees relate to the audit of our annual consolidated financial statements and the review of our interim quarterly consolidated financial statements.

 

 

(2)

These fees relate to audit related consulting.

 

 -33- 

Table of Contents

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

 

AXIL BRANDS, INC. AND SUBSIDIARIES

 

CONSOLIDATED FINANCIAL STATEMENTS 

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS  

 

May 31, 2026 and 2025 

 

CONTENTS

 

Report of Independent Registered Public Accounting Firm (PCAOB ID: 106)

F-1
   

Financial Statements:

 
   
Consolidated Balance Sheets - As of May 31, 2026 and 2025 F-2
   
Consolidated Statements of Operations - For the fiscal years ended May 31, 2026 and 2025 F-3
   
Consolidated Statements of Changes in Stockholders’ Equity - For the fiscal years ended May 31, 2026 and 2025 F-4
   
Consolidated Statements of Cash Flows - For the fiscal years ended May 31, 2026 and 2025 F-5
   
Notes to Consolidated Financial Statements F-6

 

 -34- 

Table of Contents

 

 

Report of Independent Registered Public Accounting Firm  

 

To the Stockholders and the Board of Directors of:

AXIL Brands, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of AXIL Brands, Inc. and subsidiaries (the “Company”) as of May 31, 2026 and 2025, the related consolidated statements of operations, changes in stockholders’ equity and cash flows for each of the two years in the period ended May 31, 2026, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of May 31, 2026 and 2025, and the consolidated results of its operations and its cash flows for each of the two years in the period ended May 31, 2026, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

The critical audit matters are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

 

/s/ Salberg & Company, P.A.

 

SALBERG & COMPANY, P.A.

We have served as the Company’s auditor since 2017.

Boca Raton, Florida

August 18, 2026

 

2295 NW Corporate Blvd., Suite 240 • Boca Raton, FL 33431-7326

Phone: (561) 995-8270 • Toll Free: (866) CPA-8500 • Fax: (561) 995-1920

www.salbergco.com • info@salbergco.com

Member National Association of Certified Valuation Analysts • Registered with the PCAOB

Member CPAConnect with Affiliated Offices Worldwide • Member AICPA Center for Audit Quality

  F-1 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

                 
    May 31, 2026     May 31, 2025  
             
ASSETS                
 CURRENT ASSETS:                
 Cash and cash equivalents   $ 4,462,040     $ 4,769,854  
 Accounts receivable, net     4,748,966       1,003,945  
 Inventory, net     4,419,628       2,533,658  
 Due from related party              222  
 Prepaid expenses and other current assets     712,214       947,969  
                 
 Total Current Assets     14,342,848       9,255,648  
                 
 OTHER ASSETS:                
 Property and equipment, net     389,733       412,261  
 Intangible assets, net     389,747       403,591  
 Right of use assets     360,512       579,121  
 Deferred tax asset     301,460       46,239  
 Other assets     20,720       20,720  
 Goodwill     2,152,215       2,152,215  
                 
 Total Other Assets     3,614,387       3,614,147  
                 
 TOTAL ASSETS   $ 17,957,235     $ 12,869,795  
                 
 LIABILITIES AND STOCKHOLDERS' EQUITY                
                 
 CURRENT LIABILITIES:                
 Accounts payable   $ 1,989,048     $ 866,573  
 Contract liabilities, current     389,333       707,207  
 Note payable, current              3,574  
 Due to related party     152,177           
 Lease liabilities, current     195,563       212,543  
 Income tax liability     688,150       310,369  
 Other current liabilities     1,088,262       362,558  
                 
 Total Current Liabilities     4,502,533       2,462,824  
                 
 LONG TERM LIABILITIES:                
 Lease liabilities     209,105       404,669  
 Note payable              136,655  
     Contract liabilities     101,380       205,939  
 Total Long Term Liabilities     310,485       747,263  
                 
 Total Liabilities     4,813,018       3,210,087  
                 
 Commitments and contingencies (see Note 10)                
                 
 STOCKHOLDERS' EQUITY:                
Preferred stock, $0.0001 par value; 28,000,000 shares authorized; 24,873,500 and 27,773,500 shares issued and outstanding as of May 31, 2026 and May 31, 2025, respectively     2,487       2,777  
Common stock, $0.0001 par value: 15,000,000 shares authorized; 6,822,681 and 6,657,717 shares issued and outstanding as of May 31, 2026 and May 31, 2025, respectively     682       666  
Additional paid-in capital     9,720,981       8,935,547  
    Retained Earnings     3,420,067       720,718  
                 
 Total Stockholders' Equity     13,144,217       9,659,708  

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

  $ 17,957,235      $ 12,869,795  

 

See accompanying notes to these consolidated financial statements.

 

  F-2 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE YEARS ENDED MAY 31, 2026 AND 2025

 

                 
 

 

2026

 

 

2025

 

             

Revenues, net

 

$

30,847,570

   

$

26,257,522

 
                 

Cost of revenues

   

9,467,823

     

7,615,954

 
 

 

 

 

 

 

 

 

 

Gross profit

   

21,379,747

     

18,641,568

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES:

 

 

 

 

 

 

 

 

Sales and marketing

   

12,159,478

     

11,460,342

 

Compensation and related taxes

   

2,119,368

     

1,956,084

 

Research and development

   

7,000

     

 

General and administrative

   

4,116,858

     

4,063,777

 
                 

Total Operating Expenses

   

18,402,704

     

17,480,203

 
         

 

 

 

 

INCOME FROM OPERATIONS

   

2,977,043

     

1,161,365

 

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE):

               

Other income

   

30,485

     

11,536

 

Interest income

   

134,718

     

139,813

 

Interest expense and other finance charges

   

(2,587

)

   

(3,898)

 

Other income, net

   

162,616

     

147,451

 
                 

INCOME BEFORE PROVISION FOR INCOME TAXES

   

3,139,659

     

1,308,816

 
                 

Provision for income taxes

   

440,310

     

453,828

 
                 

NET INCOME

 

$

2,699,349

   

$

854,988

 
                 

NET INCOME PER COMMON SHARE:

               

Basic

 

$

0.40

   

$

0.13

 

Diluted

 

$

0.33

   

$

0.10

 

 

               

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:

               

Basic

   

6,745,387

     

6,440,476

 

Diluted

   

8,256,118

     

8,217,083

 

 

See accompanying notes to these consolidated financial statements.

 

  F-3 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

FOR THE YEARS ENDED MAY 31, 2026 AND 2025

 

                                                         

For the year ended May 31, 2026

           

 

 

 

     
       

 

 

 

 

Additional

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid-in

 

 

Retained

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

Equity

 

Balance, May 31, 2025

   

27,773,500

   

$

2,777

     

6,657,717

   

$

666

   

$

8,935,547

   

$

720,718

   

$

9,659,708

 
                                                         

Stock option expense

   

—  

     

  

     

—  

     

  

     

669,262

     

  

     

669,262

 
                                                         

Stock-based compensation

   

—  

     

  

     

19,964

     

1

     

115,897

     

  

     

115,898

 
                                                         

Preferred shares converted to common stock

   

(2,900,000

)

   

(290

)

   

145,000

     

15

     

275

     

  

     

  

 
                                                         

Net income for the year ended May 31, 2026

   

—  

     

  

     

—  

     

  

     

  

     

2,699,349

     

2,699,349

 
                                                         

Balance, May 31, 2026

   

24,873,500

   

$

2,487

     

6,822,681

   

$

682

   

$

9,720,981

   

$

3,420,067

   

$

13,144,217

 

 

For the year ended May 31, 2025

           

 

 

 

     
          Common Stock  

 

Additional

 

 

Retained Earnings/

 

 

Total

 

 

 

Preferred Stock

 

 

Issued/Issuable

 

 

Paid-in

 

 

(Accumulated

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit)

 

 

Equity

 

Balance, May 31, 2024

   

42,251,750

   

$

4,225

     

5,908,939

   

$

591

   

$

7,825,240

   

$

(134,270

)

 

$

7,695,786

 
 

 

 

 

 

                                               

Stock option expense

 

 

—  

 

 

 

  

 

   

—  

 

 

 

  

 

   

624,559

     

  

     

624,559

 
 

 

 

 

 

               

 

 

 

 

                       

Stock-based compensation

   

—  

     

  

     

24,865

     

3

     

484,372

     

  

     

484,375

 
                                                         

Preferred shares converted to common stock

   

(14,478,250

)

   

(1,448

)

   

723,913

     

72

     

1,376

     

  

     

  

 
                                                         

Net income for the year ended May 31, 2025

   

—  

     

  

     

—  

     

  

     

  

     

854,988

     

854,988

 
                                                         

Balance, May 31, 2025

   

27,773,500

   

$

2,777

     

6,657,717

   

$

666

   

$

8,935,547

   

$

720,718

   

$

9,659,708

 

 

See accompanying notes to these consolidated financial statements.

 

  F-4 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED MAY 31, 2026 AND 2025

 

                 
 

 

2026

 

 

2025

 

             

CASH FLOWS FROM OPERATING ACTIVITIES

               

Net income

 

$

2,699,349

   

$

854,988

 

Adjustments to reconcile net income to net cash (used in)/provided by operating activities:

               

Depreciation and amortization

   

246,723

     

148,498

 

Provision/(Recovery) for credit losses

   

79,541

     

(4,519

)

Reversal of inventory obsolescence

   

  

     

(46,895

Stock-based compensation and stock option expense

   

785,160

     

1,108,934

 

Gain on forgiveness of account payable

   

  

     

(218,699

)

Deferred income taxes

   

(255,221

   

187,922

 

Change in operating assets and liabilities:

               

Accounts receivable

   

(3,824,562

)

   

(489,591

)

Inventory

   

(1,885,970

)

   

907,260

 

Prepaid expenses and other current assets

   

235,755

     

(142,668

)

Accounts payable

   

1,122,472

     

117,677

 

Other current liabilities

   

1,209,551

     

(71,699

Contract liabilities

   

(422,433

)

   

(422,547

)

                 

NET CASH (USED IN)/PROVIDED BY OPERATING ACTIVITIES

   

(9,635

)

   

1,928,661

 
                 

CASH FLOWS FROM INVESTING ACTIVITIES

               

Purchases of intangibles

   

(130,964

)

   

(180,815

)

Purchases of property and equipment

   

(79,385

)

   

(213,483

)

                 

NET CASH USED IN INVESTING ACTIVITIES

   

(210,349

)

   

(394,298

)

                 

CASH FLOWS FROM FINANCING ACTIVITIES

               

Repayment of note payable

   

(140,229

)

   

(6,365

)

Advances from a related party

   

5,939,172

     

6,950,210

 

Repayments from a related party

   

(5,886,773

)

   

(6,962,230

)

 

 

 

 

 

 

 

 

 

NET CASH USED IN FINANCING ACTIVITIES

   

(87,830

)

   

(18,385

)

 

 

 

 

 

 

 

 

 

NET (DECREASE)/INCREASE IN CASH

   

(307,814

)

   

1,515,978

 
                 

CASH AND CASH EQUIVALENTS - Beginning of year

   

4,769,854

     

3,253,876

 
                 

CASH AND CASH EQUIVALENTS - End of year

 

$

4,462,040

   

$

4,769,854

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

 

     

 

 

 

 

Cash paid during the year for:

               

Interest

 

$

3,757

   

$

3,736

 

Income taxes

 

$

317,752

   

$

137,273

 
 

 

 

 

 

       
 

 

 

 

 

       

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

               

Initial recognition of right of use assets recognized as lease liability

 

$

  

 

 

$

767,269

 

 

See accompanying notes to these consolidated financial statements.

 

  F-5 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MAY 31, 2026 AND 2025

 

Note 1 – Organization

 

AXIL Brands, Inc. (together with its subsidiaries, the “Company,” “we,” “us” or “our”) is a Delaware corporation headquartered at 9150 Wilshire Boulevard, Suite 245, Beverly Hills, California 90212. The Company is engaged in the manufacturing, marketing, sale, and distribution of high tech hearing and audio enhancement and protection products, professional quality hair and skin care products, and the delivery of marketing services. These offerings are sold or provided throughout the United States, Canada, Europe and Asia.

 

The Company changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024 and concurrently uplisted to the NYSE American stock exchange. The Company operates through its subsidiaries, including AXIL Distribution Company (formerly Reviv3 Acquisition Corporation) and Sharper Vision Marketing Inc., which was incorporated on May 5, 2025.

 

In February 2026, the Company formed Reviv3 ProCare Company, a wholly owned Delaware subsidiary, to support the strategic development of its Reviv3 hair and skin care business.

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies

 

Basis of Presentation and Principles of Consolidation

 

The consolidated financial statements for the fiscal years ended May 31, 2026 and 2025 have been prepared by us in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and include the accounts of the Company and its consolidated subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. 

 

Use of estimates

 

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. Estimates made by management include, but are not limited to, the allowance for credit losses, inventory valuations and classifications, the useful life of property and equipment, the valuation of deferred tax assets, the value of stock based compensation, contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets, and the fair value of non-cash common stock issuances. 

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications had no impact on previously reported consolidated assets, stockholders’ equity, net income or net cash flows. The Company reclassified $67,412 from customer deposits and $50,148 from current contract liabilities to other current liabilities to improve the presentation of its current liabilities. Customer deposits were reclassified to other current liabilities, and amounts related to customer refund obligations were reclassified from contract liabilities, current, as such amounts represent obligations to refund customers rather than obligations to transfer goods or services. In addition, $193,600 was reclassified from sales and marketing expenses to compensation and related taxes relating to stock based compensation expense, $915,334 was reclassified from professional and consulting expenses to compensation and related taxes relating to stock based compensation expense, and $2,360,397 was reclassified from professional and consulting expenses to general and administrative expenses relating to other professional and consulting expenses. These reclassifications had no impact on total operating expenses or income from operations for the year ended May 31, 2025.

 

Cash and cash equivalents

 

The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note 12 - Concentrations).

 

  F-6 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Accounts receivable and allowance for credit losses

 

Accounts receivable are comprised of receivables from customers and receivables from merchant processors. The Company has a policy of providing an allowance for credit losses based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to provision for credit losses and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Prepaid expenses and other current assets

 

Prepaid expenses and other current assets consist primarily of cash prepayments to vendors for inventory, operational and corporate expenditure, and prepayments for trade shows and marketing events which will be utilized within a year, and prepayments on credit cards and other current assets relating to the right to recover assets (for the cost of goods sold) associated with the right of returns for products sold. Prepayments to vendors for inventory were $145,315 and $643,131 as of May 31, 2026 and May 31, 2025, respectively.

 

Inventory

 

The Company values inventory, consisting of finished goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering historical sales and other factors and, based on this evaluation, classifies inventory markdowns in the statement of operations as a component of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory held above the expected level of sales in the next twelve months, is classified as non-current inventory. 

 

Property and Equipment, net

 

Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statement of operations.

  

Product warranty

 

The Company provides a standard limited warranty, on its hearing enhancement and hearing protection products. This warranty is considered an assurance-type warranty and is not accounted for as a separate performance obligation. The Company records the costs of repairs and replacements related to these warranties as incurred within cost of revenues. Based on historical experience, warranty claims have not been material, and accordingly, no warranty liability has been recorded as of May 31, 2026 and May 31, 2025.

 

The Company also offers a two-year or three-year limited warranty on its hearing enhancement and hearing protection products, which are sold separately. These extended warranties are considered distinct performance obligations, and the associated revenue is deferred and recognized on a straight-line basis over the warranty period. 

 

  F-7 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Revenue recognition

 

The Company follows Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.” This revenue recognition standard has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied. 

 

The Company generates revenue from the sale of electronic hearing and enhancement products, hair and skin care products, marketing services, and extended warranties. Revenue is recognized in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring goods or services to customers. Product revenue is recognized at a point in time when a purchase order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation. Revenue from marketing services and extended warranties is recognized over time as the related services are performed. Consideration paid to customers to promote and sell the Company’s products is recorded as a reduction of revenue.

 

Revenue recognized over time, consisting of marketing services and extended warranties, was approximately $801,309 and $879,256 for the years ended May 31, 2026 and 2025, respectively. All remaining revenue recognized for the years ended May 31, 2026 and 2025, was recognized at a point in time.

 

The five steps for revenue recognition are as follows:

 

Identify the contract with a customer. The Company generally considers completion of a sales order (which requires customer acceptance of the Company’s click-through terms and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone) or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts prior to shipping the product.

 

Identify the performance obligations in the contract. Performance obligations include the delivery of products, delivery of marketing services and, when purchased separately, extended warranty services. Marketing services represent distinct services that are satisfied over time. Extended warranties are distinct performance obligations. Standard product warranties are assurance-type warranties and are not separate performance obligations.

 

The Company does not assess promised goods or services as separate performance obligations if they are immaterial in the context of the contract.

 

Determine the transaction price and allocation to performance obligations. The transaction price in the Company’s customer contracts consists of both fixed and variable consideration. Fixed consideration includes amounts contractually billed to customers. Variable consideration primarily relates to estimated product returns, as customers are generally provided with rights of return of up to 30 days for the hearing protection and enhancement segment and up to 60 days for the hair and skin care segment.

 

The Company estimates variable consideration using historical return rates, current economic trends, and changes in customer demand, and includes such amounts in the transaction price only to the extent that it is probable that a significant reversal of revenue will not occur. Estimated returns are recorded as a reduction to revenue, with a corresponding refund liability included in other current liabilities on the consolidated balance sheets.

 

For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation based on relative standalone selling prices.

 

  F-8 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Recognize revenue when or as the Company satisfies a performance obligation. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue from extended warranties is recognized on a straight-line basis over the warranty period. Revenue from marketing services is recognized over time as services are performed, consistent with the pattern of transfer of control.

 

Contract liabilities represent payments received from customers prior to the Company satisfying the related performance obligations. These balances primarily relate to unredeemed gift cards, deferred warranty revenue associated with extended service warranties, and advance payments from customers. 

 

The following table presents the activity in the Company’s contract liabilities for the years ended May 31, 2026 and 2025. Revenue recognized during the year includes amounts that were included in the contract liability balance at the beginning of the year. 

 

                               

Customer Deposits

Deferred Warranty
Revenue

Gift Cards

Total

Balance, May 31, 2024

 

$

154,672

   

$

1,251,710

   

$

3,930

   

$

1,410,312

 

Cash received in advance

   

67,412

     

469,317

     

1,125

     

537,854

 

Revenue recognized

   

(154,672

)

   

(879,256

)

   

(1,092

)

   

(1,035,020

)

Balance, May 31, 2025

 

$

67,412

   

$

841,771

   

$

3,963

   

$

913,146

 

Cash received in advance

   

59,027

     

284,236

     

4,236

     

347,499

 

Revenue recognized

   

(67,412

)

   

(701,309

)

   

(1,211

)

   

(769,932

)

Balance, May 31, 2026

 

$

59,027

   

$

424,698

   

$

6,988

   

$

490,713

 

 

The following table summarizes the expected recognition of contract liabilities as of May 31, 2026:

 

       
 

 

Amount

 

2027

 

$

389,333

 

2028

   

96,880

 

2029

   

4,500

 

Total

 

$

490,713

 

 

Cost of Revenues

 

The components of cost of revenues include the cost of the product and service fees, shipping fees, customs duties, and depreciation of equipment used to bring inventory to its saleable condition. 

  

Shipping and Handling Costs

 

The Company accounts for shipping and handling fees in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expense were $971,368 and $994,743 for the fiscal years ended May 31, 2026 and 2025, respectively.

 

Marketing, selling and advertising

 

Sales, marketing and advertising costs are expensed as incurred. Advertising expense totaled $7,159,191 and $7,508,206 for the fiscal years ended May 31, 2026 and 2025, respectively, and is included in sales and marketing expenses in the accompanying consolidated statements of operations. Other sales and marketing expenses primarily included sales commissions, and other costs associated with the Company's sales and marketing activities.

 

Compensation and related taxes

 

Compensation and related taxes consist primarily of salaries, wages, bonuses, payroll taxes, stock-based compensation and other employee-related costs.

 

General and administrative

 

General and administrative expenses consist primarily of public company related costs, professional fees, insurance, rent and other corporate overhead costs.

 

  F-9 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Fair value measurements and fair value of financial instruments

 

The Company accounts for assets and liabilities measured at fair value on a recurring basis in accordance with ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”). ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below: 

 

Level 1:

Observable inputs such as quoted market prices in active markets for identical assets or liabilities.

   

Level 2:

Observable market-based inputs or unobservable inputs that are corroborated by market data.

   

Level 3:

Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

 

The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (“FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

The estimated fair value of certain financial instruments, including prepaid expenses, deposits, accounts payable and accrued expenses are carried on a historical cost basis, which approximates their fair values because of the short-term nature of these instruments.

 

Goodwill

 

Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances indicate the fair value of a reporting unit is below its carrying value.

 

The Company performs its annual goodwill impairment assessment on May 31st of each year or as impairment indicators dictate.

 

When evaluating the potential impairment of goodwill, management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach (discounted cash flow method).

 

Under the quantitative method we compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is the amount by which the carrying amount exceeds the fair value.

 

  F-10 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results. 

 

Income Taxes

 

The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” (“ASC 740-10”), which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

   

The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.

 

Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

 

The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed.

 

Impairment of long-lived assets  

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not record any impairment loss during the fiscal years ended May 31, 2026 and 2025.

 

  F-11 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Stock-based compensation

 

Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation” (“ASC 718”), which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.

 

For non-employee stock option based awards, the Company follows ASU 2018-07, which substantially aligns share-based compensation for employees and non-employees.

 

Net income per share of common stock

 

Basic net income per share is computed by dividing the net income by the weighted average number of common shares during the period. Diluted net income per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period.

 

Dilutive common stock equivalent shares consist of stock options and restricted stock awards, which are computed under the treasury stock method using the average market price during the period, and Series A Convertible Preferred Stock, which is computed under the if-converted method as if converted at the beginning of the period. 

 

The following table sets forth the computations of basic and diluted net income per common share:

 

             
   

For the Year Ended

 
   

May 31,

 

 

May 31,

 
   

2026

 

 

2025

 
             

Net income

 

$

2,699,349

   

$

854,988

 
                 

Weighted average basic shares

   

6,745,387

     

6,440,476

 

 Dilutive securities:

               

Convertible preferred stock

   

1,289,760

     

1,585,149

 

Stock options

   

210,953

     

180,430

 

Restricted stock awards

   

10,018

     

11,028

 

Weighted average dilutive shares

   

8,256,118

     

8,217,083

 
                 

Earnings per share:

               

Basic

 

$

0.40

   

$

0.13

 

Diluted

 

$

0.33

   

$

0.10

 

 

Lease Accounting

 

The Company accounts for leases in accordance with ASC 842, Leases, which requires recognition of right-of-use (“ROU”) assets and lease liabilities for substantially all leases, including those previously classified as operating leases.

 

  F-12 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

The Company treats a contract as a lease when it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. For all leases with terms greater than 12 months, the Company recognizes a ROU asset and a corresponding lease liability at the lease commencement date. The lease liability is measured at the present value of the lease payments not yet paid, discounted using the Company’s incremental borrowing rate. The ROU asset is measured as the lease liability adjusted for any initial direct costs, prepaid rent, or lease incentives.

 

The Company’s incremental borrowing rate reflects the rate of interest it would have to pay to borrow on a collateralized basis over a similar lease term and for an asset of similar value. The implicit rate in the lease is used when it is readily determinable.

 

ROU assets represent the Company’s right to use the leased asset over the lease term, while lease liabilities represent the obligation to make lease payments. Lease expense is recognized on a straight-line basis over the lease term. Variable lease payments, which depend on factors such as usage or future events, are expensed as incurred and do not result in remeasurement of the lease liability.

 

The Company reviews ROU assets for impairment consistent with the policy for long-lived assets. Recoverability is assessed whenever events or changes in circumstances indicate the carrying value of the asset may not be recoverable. The review is based on estimated future undiscounted cash flows expected from the use of the asset.

 

The Company’s lease agreements do not include residual value guarantees or restrictive covenants. The Company does not act as a lessor and does not have any finance leases at this time.

 

Segment Reporting

 

The Company follows the provisions of ASC Topic 280, Segment Reporting. Operating segments are defined as components of the business for which discrete financial information is available and regularly reviewed by the Company’s chief operating decision maker (“CODM”) to assess performance and allocate resources. The Company’s Chief Executive Officer serves as the CODM.

 

The Company has determined that it operates in three reportable segments: (i) the sale of hearing protection and hearing enhancement products, (ii) the sale of hair and skin care products, and (iii) marketing services.

 

During fiscal year 2025, the Company formed a new legal entity, Sharper Vision Marketing Inc., which provides marketing services. Beginning in the three months ended February 28, 2026, the Company determined that this business meets the criteria for separate disclosure as a reportable segment due to increased activity and the availability of discrete financial information reviewed by the CODM. Accordingly, the Company has presented this business as a separate reportable segment for the current period. Prior to this change, the results of this business were included within “All Other.”

 

The Company also provides disclosures of revenue, significant segment expense categories, and long-lived assets by geographic area, in accordance with ASC 280 and ASU 2023-07. See Note 13 – “Business Segment and Geographic Area Information” for additional information.

 

Recently Adopted Accounting Pronouncements

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments require enhanced annual income tax disclosures, including more detailed information about the effective tax rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments are effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and must be applied on a prospective basis with the option for retrospective application. The Company adopted this standard effective June 1, 2025, the beginning of its fiscal year 2026. The adoption of ASU 2023-09 did not have a material impact on the Company’s consolidated financial statements.

 

  F-13 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Recently Issued Accounting Pronouncements

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires entities to provide more detailed disaggregation of expenses in the income statement, focusing on the nature of the expenses rather than their function. The new disclosures will require entities to separately present expenses for significant line items, including but not limited to, depreciation, amortization, and employee compensation. Entities will also be required to provide a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, disclose the total amount of selling expenses and, in annual reporting periods, provide a definition of what constitutes selling expenses. This pronouncement is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company does not expect the adoption of this new guidance to have a material impact on the consolidated financial statements. 

 

In May 2025, the FASB issued ASU 2025-04, Compensation—Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a Customer, which clarifies the accounting for share-based payment awards granted by an entity as consideration payable to its customer. The amendments revise the definition of a "performance condition" to include vesting conditions based on the volume, monetary amount, or timing of a customer's purchases of goods or services from the grantor, as well as purchases made by parties that acquire the grantor's goods or services from its customers. The amendments also clarify that such awards are measured in accordance with Topic 718 both before and after the grant date, that the guidance in Topic 606 on constraining estimates of variable consideration does not apply to share-based consideration payable to a customer, and that the policy election to account for forfeitures as they occur is not available for such awards. This pronouncement is effective for fiscal years beginning after December 15, 2026, including interim periods within those fiscal years, with early adoption permitted. Entities may adopt the amendments on either a modified retrospective or a fully retrospective basis. The Company does not currently have share-based consideration payable to customers and does not expect the adoption of this new guidance to have a material impact on the consolidated financial statements.

 

In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient for estimating expected credit losses on current accounts receivable and current contract assets arising from transactions accounted for under Topic 606. The practical expedient permits entities to assume that current conditions as of the balance sheet date will remain unchanged for the remaining life of the asset when developing reasonable and supportable forecasts used to estimate expected credit losses. The amendments also provide an accounting policy election, available to entities other than public business entities, to consider certain subsequent collection activity when estimating expected credit losses. The amendments are effective for fiscal years beginning after December 15, 2025, including interim periods within those fiscal years, with early adoption permitted. The amendments are required to be applied prospectively. The Company does not expect the adoption of this new guidance to have a material impact on the consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

Note 3 – Accounts Receivable, net

 

Accounts receivable, net consisted of the following:

               
   

May 31, 2026

 

 

May 31, 2025

 

Customer receivables

 

$

4,787,882

   

$

922,616

 

Merchant processor receivable

   

95,552

     

185,719

 

Less: Allowance for credit losses

   

(134,468

)

   

(104,390

)

Total Accounts receivables, net

 

$

4,748,966

   

$

1,003,945

 

  

The following table presents the activity in the allowance for credit losses related to accounts receivable for years ended May 31, 2026 and 2025:

 

  F-14 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 3 – Accounts Receivable, net (continued)

 

       
   

Amount

 

Balance, May 31, 2024

 

$

93,312

 

Recovery of credit losses

   

(4,519

Other adjustments

   

15,597

 

Balance, May 31, 2025

 

104,390

 

Provision for credit losses

   

79,541

 

Write-offs

   

(33,866

)

Other adjustments

   

(15,597

)

Ending balance as of May 31, 2026

 

$

134,468

 

 

Note 4 – Inventory, net

 

Inventory, net consisted of the following:

 

               
   

May 31, 2026

 

 

May 31, 2025

 

Finished Goods

 

$

4,285,332

   

$

2,509,840

 

Raw Materials

   

134,296

     

23,818

 

Total Inventory

 

$

4,419,628

   

$

2,533,658

 

 

At May 31, 2026 and 2025, inventory held at third party locations amounted to $1,881,035 and $109,706, respectively. At May 31, 2026 and 2025, there was $281,000 and $174,564 inventory in- transit, respectively. The Company recorded no inventory markdowns during the fiscal year ended May 31, 2026 and recorded a reversal of previously recognized inventory obsolescence of $46,895 during the fiscal year ended May 31, 2025.

 

Note 5 – Property and Equipment, net

 

Property and equipment, stated at cost, consisted of the following:

 

                   
   

Estimated Life

 

May 31, 2026

 

 

May 31, 2025

 

Promotional display racks

 

2 years

 

$

62,944

   

$

62,944

 

Furniture and fixtures

 

5 years

   

88,613

     

57,137

 

Computer equipment

 

3 years

   

18,997

     

18,558

 

Plant equipment

 

5-10 years

   

437,499

     

390,028

 

Office equipment

 

5-10 years

   

8,838

     

8,838

 

Automobile

 

5 years

   

24,347

     

24,347

 

Less: Accumulated depreciation

       

(251,505

)

   

(149,591

)

Property and equipment, net

     

$

389,733

   

$

412,261

 

 

Depreciation expense totaled $101,914 and $62,171 for the fiscal years ended May 31, 2026 and 2025, respectively. Of these amounts, $52,525 and $31,431 were classified within cost of revenues for the years ended May 31, 2026 and 2025, respectively, with the remainder included in general and administrative expenses in the accompanying statements of operations.  

 

  F-15 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 6 – Intangible Assets, net

 

Intangible assets consisted of the following: 

 

                   
   

Estimated Life

 

May 31, 2026

 

 

May 31, 2025

 

Licensing rights

 

3 years

 

$

56,160

   

$

22,080

 

Customer relationships

 

3 years

   

70,000

     

70,000

 

Trade names

 

10 years

   

275,000

     

275,000

 

Website

 

5 years

   

100,000

     

100,000

 

Internally developed software

 

3 years

   

5,000

     

 

Product certification testing

 

3 years

   

272,699

     

180,815

 

Less: Accumulated amortization

       

(389,112

)

   

(244,304

)

Total Intangible assets, net

     

$

389,747

   

$

403,591

 

 

Amortization expense amounted to $144,809 and $86,327 for the fiscal years ended May 31, 2026 and 2025, respectively.

 

As of May 31, 2026, estimated future amortization expense for intangible assets is as follows:

       

Fiscal year ending May 31,

 

Amount 

 

2027

 

$

152,900

 

2028

   

103,860

 

2029

   

45,340

 

2030

   

31,500

 

2031

   

27,500

 

Thereafter

   

28,647

 

Total

 

$

389,747

 

 

Goodwill was $2,152,215 as of May 31, 2026 and 2025.

 

Intellectual Property

 

As of May 31, 2026, the Company held three active U.S. patents and one pending U.S. patent application relating to its core technologies. These patents expire at various times between 2035 and 2038. The Company also owns six federally registered trademarks in the United States and twelve trademarks pending, which it considers to be of material importance to its business. All registered trademarks are currently in good standing and are renewed as required.

 

The Company historically has not capitalized costs associated with internally developed patents or trademarks, as they did not meet the criteria for capitalization under U.S. GAAP. As such, no intangible assets related to intellectual property has been recorded on the accompanying consolidated balance sheets.

 

  F-16 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 7 – Other Current Liabilities

 

Other current liabilities were comprised of the following:

 

               
   

May 31, 2026

 

 

May 31, 2025

 

Pending refunds

 

$

684,496

   

$

117,560

 

Accrued expenses

   

189,113

     

24,307

 

Sales tax payable

   

214,653

     

218,828

 

Credit cards

   

-

     

1,863

 

Total other current liabilities

 

$

1,088,262

   

$

362,558

 

 

Note 8 – Notes Payable

 

In May 2020, a commercial bank granted to the Company a loan (the “Loan”) in the amount of $150,000, which was administered under the authority and regulations of the U.S. Small Business Administration pursuant to the Economic Injury Disaster Loan Program (the “EIDL”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The Loan, which was evidenced by a note dated May 18, 2020, bearing interest at an annual rate of 3.75% and was payable in installments of $731 per month, beginning May 18, 2021 until May 18, 2050. The Company had to maintain a hazard insurance policy including fire, lightning, and extended coverage on all items used to secure this loan to at least 80% of the insurable value. Proceeds from loans granted under the CARES Act are intended to be used for payroll, costs to continue employee group health care benefits, rent, utilities, and certain other qualified costs (collectively, “qualifying expenses”). The Company used the loan proceeds for qualifying expenses. During the fiscal year ended May 31, 2022, the Company received a loan forgiveness for $10,000 and an additional $10,000 of borrowing under the program. During the year ended May 31, 2026, the Company repaid the outstanding Loan balance in full. The Company recorded interest expense related to the Loan, on the accompanying consolidated financial statements, of $2,587 and $3,898, for the years ended May 31, 2026 and 2025, respectively.

 

               
 

 

May 31, 2026

 

 

May 31, 2025

 

Economic Injury Disaster Loan Program (EIDL)

 

$

  

   

$

140,229

 

Total

   

  

     

140,229

 

Less: Current portion

   

  

     

(3,574

)

Non-current portion

 

$

  

   

$

136,655

 

 

Note 9 – Stockholders’ Equity

 

Shares Authorized

 

As of May 31, 2026 and 2025, the authorized capital of the Company consisted of 15,000,000 shares of common stock, par value $0.0001 per share and 28,000,000 shares of preferred stock, par value $0.0001 per share.

 

On April 8, 2025, the Board of Directors approved, and the holders of a majority of the Company’s outstanding voting securities approved by written consent, an amendment to the Company’s Certificate of Incorporation to reduce the authorized shares of common stock from 450,000,000 to 15,000,000, authorized shares of preferred stock from 300,000,000 to 28,000,000, and designated shares of Series A Preferred Stock from 250,000,000 to 27,773,500. The par value and rights of the shares remained unchanged. The amendment became effective upon filing with the Delaware Secretary of State on May 19, 2025. 

 

  F-17 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 9 – Stockholders’ Equity (continued)

 

Preferred Stock

 

The preferred stock may be issued from time to time in one or more series. The Board is expressly authorized to provide for the issuance of all or any of the shares of the preferred stock in one or more series, and to fix the number of shares and to determine or alter, for each such series, such voting powers, full or limited, or no voting powers and such designations, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution adopted by the Board providing the issuance of such shares. The Board is also expressly authorized to increase or decrease the number of shares of any series subsequent to the issue of shares of that series. In case the number of shares of any such series shall be so decreased, the decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series.

 

During the fiscal year ended May 31, 2023, the Company issued 250,000,000 shares of non-voting Series A Preferred Stock, which, following the January 2024 reverse stock split of the Company’s common stock, are convertible into shares of the Company’s common stock at a twenty-to-one ratio. These 250,000,000 shares of non-voting Series A Preferred Stock were valued at the fair market value of $3,100,000 at issuance.

 

The holders of shares of Series A Preferred Stock have no rights to dividends with respect to such shares. No dividends or other distributions shall be declared or paid on the common stock unless and until dividends at the same rate shall have been paid or declared and set apart upon the Series A Preferred Stock, based upon the number of shares of common stock into which the Series A Preferred Stock may then be converted. Upon the dissolution, liquidation, or winding up of the Company, whether voluntary or involuntary, the holders of the Series A Preferred Stock are entitled to receive out of the assets of the Company the sum of $0.0001 per share before any payment or distribution shall be made on our shares of common stock. The Series A Preferred Stock shall not be subject to redemption at the option, election or request of the Company or any holder or holders of the Series A Preferred Stock. The shares of Series A Preferred Stock are convertible at the option of the holder thereof, into one fully paid and nonassessable share of common stock for each 20 shares of Series A Preferred Stock; provided, however, that the holder may not convert that number of shares of Series A Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the Company’s common stock as determined in accordance with Sections 13(d) and (g) of the Exchange Act and the applicable rules and regulations thereunder.

 

Effective March 24, 2025, the Company’s board of directors ratified certain past actions which provided that all shares of preferred stock that were repurchased by the Company along with those that were converted into shares of common stock would be considered retired. The Company retired 222,226,500 Series A preferred shares that were previously repurchased by the Company or converted into shares of common stock prior to such date.

 

As of May 31, 2026 and May 31, 2025, 24,873,500 and 27,773,500 shares of Series A Preferred Stock, respectively, were issued and outstanding.

 

No shares of Series A Preferred Stock were issued during the years ended May 31, 2026 and 2025.

 

During the year ended May 31, 2026, certain stockholders of 2,900,000 preferred shares converted their preferred stock into 145,000 shares of common stock.

 

During the year ended May 31, 2025, certain stockholders of 14,478,250 preferred shares converted their preferred stock into 723,913 shares of common stock.

 

Common Stock

 

As of May 31, 2026 and May 31, 2025, 6,822,681 and 6,657,717 shares of common stock, respectively, were issued and outstanding.

 

  F-18 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 9 – Stockholders’ Equity (continued)

 

See “Preferred Stock” and “Restricted Stock Awards” sections within this note for additional information regarding common stock issued during the years ended May 31, 2026 and 2025.

  

Stock Options

 

Effective February 14, 2024, the Board amended the Company’s original 2022 Equity Incentive Plan (as amended, the “Plan”), which was originally approved on March 21, 2022. The effective date of the amended Plan was October 31, 2023. The amendment and restatement of the Plan became effective December 18, 2024, following shareholder approval.

 

Under the Plan, equity-based awards may be made to employees, officers, directors, non-employee directors and consultants of the Company and its Affiliates (as defined in the Plan) in the form of (i) Incentive Stock Options (to eligible employees only); (ii) Nonqualified Stock Options; (iii) Restricted Stock; (iv) Stock Awards; (v) Performance Shares; or (vi) any combination of the foregoing. The Plan will terminate upon the close of business on March 20, 2032, unless terminated earlier in accordance with the terms of the Plan. The Board serves as the Plan administrator and may amend or terminate the Plan without stockholder approval, subject to certain exceptions. 

 

The total number of shares initially authorized for issuance under the Plan was 500,000 shares. The Plan has since been amended to increase the number of shares authorized for issuance under the Plan to 2,050,000 shares of common stock. The Plan provides for an annual increase on April 1 of each calendar year, beginning in 2022 and ending in 2031, subject to Board approval prior to such date. Such potential increase may be equal to the lesser of (i) 4% of the total number of shares of the Company’s common stock outstanding on May 31 of the immediately preceding fiscal year and (ii) such smaller number of shares as determined by the Board. The number of shares authorized for issuance under the Plan will not change unless the Board affirmatively approves an increase in the number of shares authorized for issuance prior to April 1 of the applicable year. Shares surrendered or withheld to pay the exercise price of a stock option or to satisfy tax withholding requirements will not be added back to the number of shares available under the Plan. To the extent that any shares of common stock awarded or subject to issuance or purchase pursuant to awards under the Plan are not delivered or purchased, or are reacquired by the Company, for any reason, including a forfeiture of restricted stock or failure to earn performance shares, or the termination, expiration or cancellation of a stock option, or any other termination of an award without payment being made in the form of shares of common stock will be added to the number of shares available for awards under the Plan. The number of shares available for issuance under the Plan will be adjusted for any increase or decrease in the number of outstanding shares of common stock resulting from payment of a stock dividend on common stock, a stock split or subdivision or combination of shares of common stock, or a reorganization or reclassification of common stock, or any other change in the structure of shares of common stock, as determined by the Board. Shares available for awards under the Plan will consist of authorized and unissued shares.

 

Two types of options may be granted under the Plan: (1) Incentive Stock Options, which may only be issued to eligible employees of the Company and are required to have exercise price of the option not less than the fair market value of the common stock on the grant date, or, in the case of an Incentive Stock Option granted to a Ten Percent Stockholder, 110% of the fair market value of the common stock on the grant date; and (2) Non-qualified Stock Options, which may be issued to participants under the Plan and which may have an exercise price less than the fair market value of the common stock on the grant date, but not less than par value of the stock.

 

The Board may grant or sell restricted stock to participants (i.e., shares that are subject to restrictions or limitations as to the participant’s ability to sell, transfer, pledge or assign such shares) under the Plan. Except for these restrictions and any others imposed by the Board, upon the grant of restricted stock, the recipient generally will have rights of a stockholder with respect to the restricted stock. During the applicable restriction period, the recipient may not sell, exchange, transfer, pledge or otherwise dispose of the restricted stock. The Board may also grant awards of common stock to participants under the Plan, as well as awards of performance shares, which are awards for which the payout is subject to achievement of such performance objectives established by the Board. Performance shares may be settled in cash.

 

  F-19 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 9 – Stockholders’ Equity (continued)

 

Each equity-based award granted under the Plan will be evidenced by an award agreement that specifies the terms of the award and such additional limitations, terms and conditions as the Board may determine, consistent with the provisions of the Plan.

 

Subject to the Plan’s terms, the Board has full power and authority to determine whether, to what extent and under what circumstances any outstanding award will be terminated, canceled, forfeited or suspended. Awards that are subject to any restriction or have not been earned or exercised in full by the recipient will be terminated and canceled if such recipient is terminated for cause, as determined by the Board in its sole discretion.

 

The Company estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors which are subject to ASC 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes compensation on a straight-line basis over the requisite service period for each award.

 

The Company utilizes the simplified method to estimate the expected term of stock options granted to employees, as permitted under SEC Staff Accounting Bulletin No. 107. Under this method, the expected term is calculated as the midpoint between the vesting date and the contractual term of the award. The simplified method was used as the Company does not have sufficient historical data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased.

 

On March 18, 2026, the Company issued stock options to one employee to purchase, in aggregate, up to 5,000 shares of its common stock, at an exercise price of $5.30 per share valued at $25,401 and expiring on March 18, 2036. The options vested immediately on March 18, 2026.

 

On January 2, 2025, the Company issued stock options to one employee to purchase, in aggregate, up to 5,000 shares of its common stock, at an exercise price of $4.00 per share valued at $20,000 and expiring on December 31, 2034. The options vest quarterly over a year beginning on March 1, 2025.

 

On November 13, 2024, the Company issued stock options to one employee to purchase, in aggregate, up to 5,000 shares of its common stock, at an exercise price of $4.00 per share valued at $20,000 and expiring on October 31, 2034. The options vest quarterly over a year beginning on February 28, 2025.

 

On October 14, 2024, the Company issued to two Company officers stock options to purchase, in the aggregate, up to 600,000 shares of its common stock, at an exercise price of $4.01 per share valued at $2,406,000 and expiring in ten years from the date of grant. The options vest over forty-eight equal monthly installments starting on October 31, 2024.

 

As of May 31, 2026, unrecognized share-based compensation cost related to unvested stock options totaled $1,424,649, which is expected to be recognized over a weighted-average period of less than 2.4 years.

 

The fair value of stock options granted during the years ended May 31, 2026 and 2025 was estimated on the grant date using the Black-Scholes option pricing model with the following assumptions:

 

  F-20 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 9 – Stockholders’ Equity (continued)

 

               
         
   

2026

   

2025

 

Risk free interest rate

     

3.96

%

 

3.84% - 4.43

%

Expected life

     

6 years

   

5 - 7 years

 

Expected volatility

     

168

%

 

458% - 467

%

Expected dividend

     

-

   

-

 

  

The following table summarizes the activities for the Company’s stock option activity for the years ended May 31, 2026 and 2025: 

 

            
   Number of Options  Weighted Average Exercise Price  Weighted Average Remaining Term  Intrinsic Value (1)
Outstanding as of May 31, 2024   268,750   $1.83    7.8   $1,839,594 
Granted   634,000    4.17           
Exercised/Forfeited                      
Outstanding as of May 31, 2025   902,750   $3.48    8.7   $1,382,078 
Granted   5,000    5.30           
Exercised/Forfeited                      
Outstanding as of May 31, 2026   907,750    3.49    7.7    2,974,703 
Outstanding and Exercisable at May 31, 2026   557,750   $3.16    7.2   $2,029,703 

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period.

 

During the year ended May 31, 2026, the Company expensed $669,262 with respect to options, included in Compensation and related taxes in the accompanying consolidated statements of operations. During the year ended May 31, 2025, the Company expensed $624,559 with respect to options included in Compensation and related taxes in the accompanying consolidated statements of operations. 

 

Restricted Stock Awards

 

The Company’s non-employee directors participate in the Company’s non-employee director compensation arrangements. Under the terms of those arrangements and pursuant to the Plan, on January 15, 2026, the Company granted each of its three non-employee director Board members 5,000 restricted stock awards for an aggregate of 15,000 shares of the Company’s common stock that will vest on the one-year anniversary of the grant, subject to the respective director’s continued service as a member of the Board, with a total grant date fair value of $119,550 based on the stock price on the grant date.

 

Effective May 7, 2026, the Company issued 4,964 shares of restricted stock to a consultant. Fifty percent of the shares vested immediately upon grant, and the remaining shares are scheduled to vest on November 30, 2026, subject to the consultant’s continued service through that date. The total grant date fair value of the award was $34,996 based on the stock price on the grant date.

 

Effective April 10, 2025, the Company issued 7,865 shares of restricted stock to a consultant. Fifty percent of the shares vested immediately upon grant, and the remaining shares vested on November 30, 2025, and were subject to the consultant’s continued service through that date. The total grant date fair value of the award was $35,786 based on the stock price on the grant date.

  

Effective January 13, 2025, the Company granted each of its three non-employee director Board members 5,000 restricted stock awards for an aggregate of 15,000 shares of the Company’s common stock, which vested on the one-year anniversary of the grant, subject to the respective director’s continued service as a member of the Board, with a total grant date fair value of $62,250.

 

Effective November 13, 2024, the Company issued 2,000 shares of restricted stock awards to a consultant for services relating to expansion of the Company into new markets. The shares were valued at $8,000 based on the Company’s closing price on the NYSE American on the date of grant. The shares vested upon grant and were expensed over the six month service period of the consultant beginning from the grant date. 

 

  F-21 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 9 – Stockholders’ Equity (continued)

 

The fair value of the stock grants is recorded over the term of the service related to each grant. During the year ended May 31, 2026, the Company expensed $115,898 related to restricted stock awards, which was included in Compensation and related taxes in the accompanying consolidated statements of operations. During the year ended May 31, 2025, the Company expensed $484,375 related to restricted stock awards which was included in Compensation and related taxes in the accompanying consolidated statements of operations. 

 

As of May 31, 2026, there were 17,482 unvested restricted stock awards outstanding with a weighted-average grant-date fair value of $7.84, all of which are expected to vest within one year. As of May 31, 2026, unrecognized share-based compensation cost related to unvested restricted stock awards totaled $91,353, which is expected to be recognized over a weighted-average period of less than one year.

 

The following table summarizes the unvested restricted stock awards for the years ended May 31, 2026 and 2025:

 

      
      Weighted -
      Average
   Number of  Grant
   Award Shares  Date Fair Value
       
 

Unvested at May 31, 2024

    15,000   $13.00 
             
 

Granted

    22,865    4.29 
             
 

Vested

    (18,933)   11.24 
             
 

Unvested at May 31, 2025

    18,932   $4.23 
             
 

Granted

    19,964    7.74 
             
 

Vested

    (21,414)   4.56 
             
 

Unvested at May 31, 2026

    17,482   $7.84 

 

Note 10 – Commitments and Contingencies

 

Leases

 

The Company had a lease agreement in connection with its previous office and warehouse facility in California under an operating lease which expired in October 2019. On December 1, 2019, the Company signed an extension of the lease for 3 years. The rent was $7,567 per month for the first year and increased by a certain amount each year. In November 2022, the Company entered into an extension of the lease for a two-year term beginning December 1, 2022. The rent was $6,098 per month for the first year and increased by a certain amount the following year. Upon expiration of the lease on December 1, 2024, the Company did not renew the lease.

 

  F-22 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 10 – Commitments and Contingencies (continued)

 

On October 12, 2024, the Company entered into a lease in Beverly Hills, California for a term beginning November 1, 2024 and ending January 31, 2029. The base rent is $11,168 per month for the first twelve months and shall increase for each twelve-month period thereafter. The lease provides for rent abatement during months 2, 15, and 30.

 

On September 10, 2024, the Company entered into a sublease in American Fork, Utah for a three-year term beginning October 1, 2024 and continues through September 30, 2027. The base rent was $0 for the first three months and $7,684 per month for the next nine months. The rent shall increase for each twelve-month period, thereafter. An additional amount of $1,210 shall be due each month for additional overhead. The Company previously leased warehouse space in Utah under a month-to-month lease agreement.

 

The Company’s lease agreements do not contain any residual value guarantees or restrictive covenants. The Company’s lease agreements do not have an explicit renewal option, and the termination options are available in the event of material breaches. Both leases are classified as operating leases under ASC 842.

 

The Company computed an initial lease liability of $767,269 for the two new lease agreements and an initial ROU asset in the same amount which was recorded on the books at the commencement of the leases in fiscal 2025. During the years ended May 31, 2026 and May 31, 2025, the Company recorded operating lease costs in the amount of $252,643 and $193,077, respectively. Operating lease and short-term lease expenses are included in General and administrative expenses on the accompanying consolidated statements of operations. 

 

The weighted average remaining term and discount rate for the Company’s operating leases as of May 31, 2026, was 2.5 years and 13.1%, respectively.

 

Supplemental balance sheet information related to leases was as follows:

 

               

Assets

 

May 31, 2026

 

 

May 31, 2025

 

Right of use assets

 

$

729,324

   

$

861,294

 

Accumulated reduction

   

(368,812

)

   

(282,173

)

Operating lease assets, net

 

$

360,512

   

$

579,121

 
                 

Liabilities

               

Lease liabilities

 

$

729,324

   

$

861,294

 

Accumulated reduction

   

(324,656

)

   

(244,082

)

Total lease liabilities, net

   

404,668

     

617,212

 

Current portion

   

(195,563

)

   

(212,543

)

Non-current portion

 

$

209,105

   

$

404,669

 

 

Maturities of operating lease liabilities were as follows as of May 31, 2026:

       

Operating Lease (fiscal year-end)

     

2027

 

$

257,647

 

2028

   

206,270

 

2029

   

119,790

 

Total

 

$

583,707

 

Less: Imputed interest

   

(179,039

)

Present value of lease liabilities

 

$

404,668

 

 

  F-23 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 10 – Commitments and Contingencies (continued)

 

Accounts Payable

 

During the year ended May 31, 2025, the Company renewed its relationship with an entity, and as a result of the agreement, $218,699 previously due in relation to royalties, was forgiven and included in Sales and marketing in the accompanying Consolidated Statements of Operations in the year ended May 31, 2025.

 

Inventory purchase commitments

 

We place purchase orders with a concentrated group of third-party manufacturers, and as of May 31, 2026 we had outstanding, noncancellable inventory purchase commitments of approximately $1,080,000, substantially all of which are expected to be settled within twelve months.

 

Tariff matters (IEEPA duties)

 

On February 20, 2026, the U.S. Supreme Court held in Learning Resources, Inc. v. Trump that the International Emergency Economic Powers Act (“IEEPA”) does not authorize the President to impose tariffs, invalidating duties previously collected on imports subject to IEEPA-based tariff orders. Following that decision, the U.S. Court of International Trade (“CIT”) ordered U.S. Customs and Border Protection (“CBP”) to implement a refund process for all affected importers. In response, CBP developed the Consolidated Administration and Processing of Entries (“CAPE”) system, a phased automated refund mechanism that became operational on April 20, 2026.

 

As of May 31, 2026, the refund process remained subject to significant legal and administrative uncertainty. The Company has applied a gain contingency model in accordance with ASC 450-30, “Gain Contingencies” to account for potential recoveries of previously paid IEEPA tariffs. Under this model, a gain contingency is not recognized in the financial statements until the gain is realized or realizable. Any refunds, when recognized, are reflected as a reduction of Inventories on the consolidated balance sheets to the extent the related goods remain on hand, or as a reduction of cost of goods sold in the consolidated statements of operations for amounts related to goods already sold.

 

During the year ended May 31, 2026, the Company recognized approximately $60,000 of realized or realizable IEEPA tariff refunds included in cost of revenues in the accompanying consolidated statements of operations.

 

Contingencies

 

From time to time, we become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings are inherently uncertain, and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.

 

  F-24 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 11 – Related Party Transactions

 

The Company’s Chairman and Chief Executive Officer, Jeff Toghraie, is the managing director of Intrepid Global Advisors (“Intrepid”). Intrepid has, from time to time, provided advances to the Company for working capital purposes and is paid consulting fees throughout the year.  The Company recorded and paid Intrepid $291,100 and $227,100 in consulting fees for the year ended May 31, 2026 and 2025, respectively. At May 31, 2026, the Company had a payable to Intrepid of $52,177 and as of May 31, 2025 an amount receivable from Intrepid of $222 relating to an overpayment. During the year ended May 31, 2026, advances from Intrepid were $5,939,172 and repayments to Intrepid were $5,886,773. During the year ended May 31, 2025, advances from Intrepid were $6,950,210 and repayments to Intrepid were $6,962,230.  Advances made from Intrepid are short-term in nature, non-interest bearing and relate to credit utilization by the Company, primarily in connection with the Company’s marketing and advertising campaigns.

 

The Company’s Board Member, Chief Financial Officer, and Chief Operating Officer is the co-owner, Chairman and Chief Financial Officer of, and has a controlling interest in BZ Capital Strategies. The Company recorded consulting fees to BZ Capital Strategies totaling $265,000 and $120,000 for the years ended May 31, 2026 and 2025, respectively. As of May 31, 2026 and 2025, the Company had a payable to BZ Capital Strategies of $100,000 and $0, respectively.

 

Note 12 – Concentrations

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of trade accounts receivable and cash deposits, investments and cash equivalents instruments. The Company maintains its cash in bank deposits accounts. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At May 31, 2026 and 2025, the Company held cash of $3,962,040 and $4,019,854, respectively, in excess of federally insured limits. The Company has not experienced any losses in such accounts through May 31, 2026.

 

Concentration of Revenue, Accounts Receivable, Product Line, and Supplier – Hearing Enhancement and Protection Products

 

The majority of hearing enhancement and protection products are sold direct-to-consumer. There was one single customer that accounted for approximately 24% of segment revenues and 23% of consolidated revenues for the year ended May 31, 2026. There was no single customer that accounted for more than 10% of segment revenues or consolidated revenues in the year ended May 31, 2025.

 

During the fiscal year ended May 31, 2026, hearing enhancement and protection sales to customers outside the United States represented approximately 2% of segment net revenues, which consisted of 1.4% from Canada and the remaining from various countries. During the fiscal year ended May 31, 2025, hearing enhancement and protection sales to customers outside the United States represented approximately 5% segment net revenues, which consisted of 2.9% from Canada and the remaining from various countries. 

 

During the fiscal years ended May 31, 2026 and 2025 sales of hearing enhancement and protection products were comprised of the following: 

 

  F-25 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 12 – Concentrations (continued)

 

               
 

 

For The Fiscal Years Ended May 31,

Hearing Enhancement and Protection Products

 

2026

 

2025

In-ear protection devices

   

81

%

   

85

%

Over-ear protection devices

   

17

%

   

12

%

Accessories and others

   

2

%

   

3

%

Total

   

100

%

   

100

%

 

As of May 31, 2026, one customer accounted for accounts receivable greater than 10% of segment accounts receivable, aggregating to 69%. As of May 31, 2025, two customers accounted for accounts receivable greater than 10% of segment accounts receivable, aggregating to 26% consisting of 13% each.  

 

Manufacturing is outsourced primarily overseas via a number of third-party vendors. The largest vendor accounted for 79% of all purchases related to hearing enhancement and protection products, for the year ended May 31, 2026 and the two largest vendors accounted for 67% and 23%, respectively, of all purchases related to hearing enhancement and protection products for the year ended May 31, 2025.

 

Concentration of Revenue, Accounts Receivable, Product Line, and Supplier – Hair and Skin Care Products

 

During the fiscal year ended May 31, 2026, hair and skin care product sales to three customers represented over 10% of total segment sales, aggregating to 45% (13%, 13% and 19%, respectively) of the segment’s net sales, and 1.7% of the Company’s consolidated net revenues. During the fiscal year ended May 31, 2025, hair and skin care product sales to one customer represented over 10% of total segment sales, aggregating to 36% of the segment’s net sales, and 2.1% of the Company’s consolidated net revenues. 

 

During the fiscal year ended May 31, 2026, hair and skin care product sales to customers outside the United States represented approximately 45% of segment net sales, which consisted of 42% from Canada and 3% primarily from Italy and during the fiscal year ended May 31, 2025, hair and skin care product sales to customers outside the United States represented approximately 31% of segment net sales, which consisted of 28% from Canada and 3% from Italy.

 

During the fiscal year ended May 31, 2026, hair and skin care product sales by product line which each represented over 10% of the segment sales consisted of approximately 26% from sales of hair shampoo, and 22% from sales of hair conditioner and 29% from bundle kits and 23% of ancillary products. During the fiscal year ended May 31, 2025, hair and skin care product sales by product line which each represented over 10% of the segment sales consisted of approximately 31% from sales of hair shampoo, and 24% from sales of hair conditioner and 21% from bundle kits.

 

During the fiscal years ended May 31, 2026 and 2025, sales for the hair and skin care product lines comprised of the following:

 

               
 

 

For the Fiscal Years ended

Hair and Skin Care Products

 

May 31, 2026

 

May 31, 2025

Shampoos and Conditioners

   

77

%

   

76

%

Ancillary Products

   

23

%

   

24

%

Total

   

100

%

   

100

%

 

At May 31, 2026, one customer accounted for 50% of accounts receivable related to hair and skin care products. At May 31, 2025, accounts receivable for hair and skin care products that accounted for more than 10% of the segment’s total accounts receivable aggregated to 60% and represented three customers at 28%17%, and 15%, respectively. 

 

  F-26 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 12 – Concentrations (continued)

 

Hair and skin care products purchased inventories and products from three vendors represented approximately 91% of segment purchases at 62%, 18%, and 11%, respectively, during the year ended May 31, 2026, and during the year ended May 31, 2025 two vendors represented approximately 98% of segment purchases at 79% and 19%, respectively.

 

Note 13 – Business Segment and Geographic Area Information

 

Business Segments

 

The Company operates in three reportable segments: Hearing Enhancement and Protection, Hair and Skin Care, and Marketing Services. The segments are determined based on the nature of the products and services provided and how the business is managed.

  

On May 5, 2025, the Company incorporated a new wholly owned subsidiary, Sharper Vision Marketing Inc., which provides marketing services. Beginning in the three months ended February 28, 2026, the Company determined that this business meets the criteria for separate disclosure as a reportable segment due to increased activity and the availability of discrete financial information reviewed by the Chief Operating Decision Maker (“CODM”).

 

The CODM is the Company’s Chief Executive Officer. The CODM evaluates segment performance and allocates resources based primarily on a segment profit measure referred to as Segment non-cash operating income, which the Company has concluded is the measure of segment profitability. This non-GAAP measure is defined as operating income from segment operations before depreciation and amortization, stock-based compensation expense, and corporate expenses. Corporate expenses primarily include insurance, expenses related to operating as a public company—including fees paid to related parties for executive management services—corporate office rent, and stock-based compensation for management.

 

The CODM reviews Segment non-cash operating income for each segment regularly to assess performance and to make decisions regarding the allocation of resources. Segment cost of sales excludes depreciation of equipment used to bring inventory to its saleable condition; all depreciation and amortization is deducted in the reconciliation of Segment non-cash operating income to income from operations below.

 

A reconciliation of Segment non-cash operating income to the most directly comparable measure under U.S. GAAP, Income from Operations, is included in the table below.

 

  F-27 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 13 – Business Segment and Geographic Area Information (continued)

 

                                   
   For the Year Ended,
   May 31, 2026  May 31, 2025
   Hearing enhancement and protection  Hair and skin care  Marketing Services  Consolidated  Hearing enhancement and protection  Hair and skin care  Consolidated
                      
Revenues, net  $29,558,574   $1,188,996   $100,000   $30,847,570   $24,735,101   $1,522,421   $26,257,522 

Segment cost of revenues(1)

   8,876,341    533,957    5,000    9,415,298    6,896,814    687,709    7,584,523 
Segment gross profit  $20,682,233   $655,039   $95,000   $21,432,272   $17,838,287   $834,712   $18,672,999 
Operating expenses (Adjusted for non-cash items):                                   
Sales and marketing  $11,579,289   $580,189   $     $12,159,478   $11,000,206   $452,136   $11,452,342 
Compensation and related taxes   1,333,553                1,333,553    814,603    32,547    847,150 
Research and development   7,000                7,000                   
General and administrative   2,324,622    122,461    3,508    2,450,591    2,511,583    192,969    2,704,552 
Total segment expenses adjusted for non-cash items  $15,244,464   $702,650   $3,508   $15,950,622   $14,326,392   $677,652   $15,004,044 
Segment non-cash operating income (loss)  $5,437,769   $(47,611)  $91,492   $5,481,650   $3,511,895   $157,060   $3,668,955 
Depreciation and amortization                  (246,723)             (148,498)
Stock-based compensation                  (785,160)             (1,108,934)

Corporate expenses(2)

                  (1,472,724)             (1,250,158)
Income from Operations                 $2,977,043             $1,161,365 
Payments for property and equipment and intangible assets  $210,349   $     $     $210,349   $392,428   $1,870   $394,298 
Depreciation and amortization  $242,993   $3,730   $     $246,723   $144,955   $3,543   $148,498 

Total segment assets(3)

  $13,641,930   $3,903,116   $101,492   $17,646,538   $8,109,272   $4,760,523   $12,869,795 
Corporate assets                 $310,697             $   
Total assets                 $17,957,235             $12,869,795 

 

  F-28 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 13 – Business Segment and Geographic Area Information (continued)

 

(1)Segment cost of revenues excludes depreciation expense of $52,525 and $31,431 for the years ended May 31, 2026 and 2025, respectively, which is included in cost of revenues in the consolidated statements of operations.
(2)Corporate expenses primarily include insurance, expenses related to operating as a public company, including fees paid to related parties for executive management services, corporate office rent, and stock-based compensation for management.
(3)As of May 31, 2025, Total assets in the Company's Hearing enhancement and protection segment includes $10,000 related to cash held by the Company’s subsidiary included in marketing services in the fiscal year ended May 31, 2026.

 

Geographic Area Information

 

During the fiscal years ended May 31, 2026 and 2025, approximately 96% and 93%, respectively, of our consolidated net revenues were to customers located in the U.S. (based on the customer’s shipping address). All Company assets are located in the United States.

 

Disaggregation of Revenue

 

The following table disaggregates revenue from contracts with customers by sales channel and by reportable segment, which the Company has determined depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Direct-to-consumer revenue comprises sales through the Company’s owned e-commerce sites and third-party online marketplaces. Retail and wholesale revenue comprises sales to national retail chains, specialty retailers, dealers, distributors and international distribution partners. Marketing services revenue comprises fee-based performance marketing services provided to third-party clients. The table below reconciles disaggregated revenue to the segment revenue presented above and to revenues, net in the consolidated statements of operations.

 

                    
  

Hearing enhancement and protection

 

Hair and skin care

 

Marketing services

 

Consolidated

For the year ended May 31, 2026

                    

Direct-to-consumer

  $19,695,815   $243,381   $     $19,939,196 

Retail and wholesale

   9,862,759    945,615          10,808,374 

Marketing services

               100,000    100,000 

Total revenues, net

  $29,558,574   $1,188,996   $100,000   $30,847,570 
                     

For the year ended May 31, 2025

                    

Direct-to-consumer

  $20,571,528   $299,562   $     $20,871,090 

Retail and wholesale

   4,163,573    1,222,859          5,386,432 

Total revenues, net

  $24,735,101   $1,522,421   $     $26,257,522 

 

  F-29 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 14 – Income Taxes

 

The Company is subject to U.S. federal tax of 21.0% and California state tax rate of 8.84% and Utah State tax rate of 4.45%.

 

The Company accounts for income taxes under ASC 740. For the year ended May 31, 2026, the Company recorded income tax expense of $440,310, consisting of current federal tax expense of $620,781, current state tax expense of $74,752, deferred federal income tax benefit of ($149,928), and deferred state income tax benefit of ($105,295).

 

The income taxes expense for years ended May 31, 2026 and 2025 consisted of the following:

               
 

 

For The Fiscal Years Ended May 31,

 

 

2026

 

2025

         

Current

               

Federal

 

$

620,781

   

$

206,950

 

State

   

74,752

     

61,530

 
                 

Deferred

               

Federal

   

(149,928

   

268,985

 

State

   

(105,295

)

   

(83,637

 Income tax expense

 

$

440,310

   

$

453,828

 

 

Income taxes paid, net of refunds received, were $317,749 and $137,273 for the years ended May 31, 2026 and 2025, respectively. Income taxes paid, net of refunds received, for the year ended May 31, 2026 consisted of $241,500 paid to U.S. federal taxing authorities and $76,249 paid to state taxing authorities primarily in Utah. The Company paid no foreign income taxes during either period. No individual state jurisdiction other than Utah accounted for more than 5% of income taxes paid.

 

The Company’s effective tax rate was 14.0% for the year ended May 31, 2026, compared with the U.S. federal statutory rate of 21.0%. The primary reconciling item was state and local income tax, net of federal benefit, of ($25,468). Other reconciling items included permanent differences of $9,073, return-to-accrual adjustments of ($15,539), and R&D credits of ($187,085). 

               
 

 

For The Fiscal Year Ended May 31,

 

 

2026

 

Tax Rate

Tax expense computed at statutory rate of 21%

 

$

659,329

     

21.00%

 

State and local income tax, net of federal benefit

   

(25,468

)

   

(0.81%

)

Permanent differences

   

9,073

     

0.29%

 

Return-to-accrual adjustment

   

(15,539

   

(0.49%

Tax credits – R&D credits

   

(187,085

   

(5.96%)

 

Income tax expense

 

$

440,310

     

14.02%

 

 

The Company’s effective tax rate was 34.7% for the year ended May 31, 2025, compared with the U.S. federal statutory rate of 21.0%. The primary reconciling item was return-to-accrual adjustments of $173,638. Other reconciling items included permanent differences of $42,327 and state and local income tax, net of federal benefit, of ($36,988).

 

  F-30 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 14 – Income Taxes (continued)

 

                 
 

 

For The Fiscal Year Ended May 31,

 

 

2025

 

Tax Rate

Tax expense computed at statutory rate of 21%

 

$

274,851

     

21.00%

 

State and local income tax, net of federal benefit

   

(36,988

)

   

(2.83%

)

Permanent differences

   

42,327

     

3.23%

 

Return-to-accrual adjustment

   

173,638

     

13.27%

 

Tax Credits – R&D credits

   

-

     

-

 

Tax expense

 

$

453,828

     

34.67%

 

 

Deferred taxes reflect the tax effects of temporary differences and carryforwards. At May 31, 2026, the Company had a net deferred tax asset of $301,460, compared with $46,239 at May 31, 2025. Significant components include stock-based compensation of $347,762, net operating loss carryforwards of $127,551, property, plant and equipment of ($95,853), intangibles of ($33,036), and other items of ($44,964).

 

The effects of temporary differences that gave rise to significant portions of deferred tax assets and liabilities at May 31, are as follows:

 

       
 

 

As of May 31,

 

 

2026

 

2025

         

Deferred tax assets

               

Property, Plant and Equipment

 

$

(95,853

)

 

$

(101,415

)

Intangibles

   

(33,036

)

   

(59,238

)

Net operating loss

   

127,551

     

90,060

 

Stock-based compensation

   

347,762

     

163,018

 

Other

   

(44,964

)

   

(46,186

)

Net deferred tax assets before valuation allowance

   

301,460

     

46,239

 

Less: Deferred tax asset valuation allowance

   

-

     

-

 
                 

Deferred tax liabilities

   

-

     

-

 

Total net deferred tax assets

 

$

301,460

   

$

46,239

 

 

There was no valuation allowance as of May 31, 2026 and 2025.

 

Gross deferred tax assets were $475,313 and $253,078 at May 31, 2026 and 2025, respectively, and gross deferred tax liabilities were $(173,853) and $(206,839), respectively. Deferred tax liabilities relate to property, plant and equipment, intangibles and other items and are presented above as negative amounts within the components table. No valuation allowance was recorded at either date, resulting in net deferred tax assets of $301,460 and $46,239 at May 31, 2026 and 2025, respectively.

 

As of May 31, 2026, the Company had California net operating loss (“NOL”) carryforwards of $1,826,430. These NOLs are available to offset future taxable income in California, subject to applicable limitations. California NOLs are generally subject to a 20-year carryforward period. As of May 31, 2026, the Company did not have any federal or Utah NOL carryforwards. Based on recent operating results and projected future income, management believes it is more likely than not that the remaining NOL carryforwards will be fully realized. Accordingly, no valuation allowance has been recorded as of May 31, 2026.

 

  F-31 

 

Table of Contents

 

AXIL BRANDS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2026 AND 2025

 

Note 15 – Subsequent Events

 

Subsequent to May 31, 2026 and prior to the issuance of these consolidated financial statements, the Company received cash of approximately $910,000 from CBP in respect of refunds of IEEPA duties previously paid, including interest. Of the duty portion, approximately $555,000 relates to customs duties previously charged to Cost of revenues on goods that had been sold as of May 31, 2026, and approximately $320,000 relates to customs duties capitalized in Inventory, net at May 31, 2026, and $35,000 relates to interest. No refund claims of IEEPA duties remain outstanding as of the date of this filing.

 

  F-32 

 

Table of Contents

 

(b) Exhibits

 

                Incorporated by Reference
Exhibit Number   Exhibit Description   Filed herewith   Furnished herewith   Form   Period Ending   Exhibit   Filing Date
2.1+   Asset Purchase Agreement, dated as of May 1, 2022, among AXIL Brands, Inc. (f/k/a Reviv3 Procare Company), AXIL Distribution Company (f/k/a Reviv3 Acquisition Corporation), Axil & Associated Brands Corp., and Certain Stockholders of Axil & Associated Brands Corp.           8-K       10.1   6/22/2022
2.2   Amendment Number 1 to Asset Purchase Agreement, effective as of June 10, 2022, among AXIL Brands, Inc. (f/k/a Reviv3 Procare Company), AXIL Distribution Company (f/k/a Reviv3 Acquisition Corporation), Axil & Associated Brands Corp., and Certain Stockholders of Axil & Associated Brands Corp.           8-K       10.2   6/22/2022
2.3   Amendment to Asset Purchase Agreement, dated September 8, 2022, between AXIL Brands, Inc. (f/k/a Reviv3 Procare Company), AXIL Distribution Company (f/k/a Reviv3 Acquisition Corporation), and Axil & Associated Brands Corp. and Certain Stockholders of Axil & Associated Brands Corp.           10-Q   8/31/2022   10.2   10/12/2022
3.1   Amended and Restated Certificate of Incorporation           S-1       3.3   10/6/2017
3.2   Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective as of June 13, 2022)           10-K   5/31/2022   3.3   8/25/2022
3.3   Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective as of January 16, 2024)           8-K       3.1   1/16/2024
3.4   Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective as of February 14, 2024)           8-K       3.1   2/12/2024
3.5   Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective as of May 19, 2025)           8-K       3.1   5/19/2025
3.6   Bylaws           S-1       3.2   10/6/2017
3.7   Amendment to the Bylaws (effective as of February 14, 2024)           8-K       3.2   2/12/2024
4.1   Description of the Company’s Registered Securities   X                    
4.2   Form of Common Stock Certificate of AXIL Brands, Inc.           10-K   5/31/2024   4.2   8/15/2024
10.1   Contribution Agreement between Reviv3 Procare, LLC and AXIL Brands, Inc. (f/k/a Reviv3 Procare Company), dated June 1, 2015           S-1       10.1   10/6/2017

 

  -35- 

 

Table of Contents

 

10.2*

 

2022 Equity Incentive Plan (March 2022)

         

10-K

 

5/31/2022

 

10.8

 

8/25/2022

10.3*

 

Amendment to the 2022 Equity Incentive Plan (effective as of February 14, 2024)

         

8-K

     

10.1

 

2/15/2024

10.4*

 

Amended and Restated 2022 Equity Incentive Plan (effective as of December 18, 2024)

         

8-K

     

10.1

 

12/18/2024

10.5*

 

Form of Option Award Agreement (2022)

         

10-K

 

5/31/2022

 

10.9

 

8/25/2022

10.6*

 

Form of Stock Option Agreement (2023)

         

10-K

 

5/31/2023

 

10.9

 

8/21/2023

10.7*

 

Form of Restricted Stock Grant Agreement (2023)

         

10-K

 

5/31/2023

 

10.10

 

8/21/2023

10.8*

 

Form of Performance Restricted Stock Unit Agreement (2023)

         

10-K

 

5/31/2023

 

10.11

 

8/21/2023

10.9*

 

Form of Stock Option Agreement (2024)

         

10-Q

 

8/31/2024

 

10.1

 

10/10/2024

10.10*

 

Form of Restricted Stock Award Agreement (2024)

         

10-Q

 

11/30/2024

 

10.3

 

1/8/2025

10.11

 

Form of Securities Purchase Agreement

         

10-Q

 

11/30/2022

 

10.5

 

1/10/2023

10.12

 

Form of Securities Purchase Agreement

         

8-K

     

10.1

 

3/3/2023

10.13

 

Repurchase Agreement, dated March 5, 2024, by and between AXIL Brands, Inc. and Teton 360, LLC

         

8-K

     

10.1

 

3/11/2024

10.14

 

Repurchase Agreement, dated March 5, 2024, by and between AXIL Brands, Inc. and L Grant Foster TTEE - The Williams Family Irrevocable Trust

         

8-K

     

10.2

 

3/11/2024

10.15*

 

Employment Agreement, dated August 18, 2025, by and between AXIL Brands, Inc. and Jeff Toghraie.

          10-K  

5/31/2025

 

10.19

 

8/21/2025

10.16*

 

Employment Agreement, dated August 18, 2025, by and between AXIL Brands, Inc. and Jeff Brown.

          10-K  

5/31/2025

 

10.20

 

8/21/2025

19.1

 

Insider Trading Policy (last revised October 8, 2024)

 

      10-K   5/31/2025    19.1    8/21/2025
21.1   Subsidiaries of the Company   X                    
23.1   Consent of Independent Registered Public Accounting Firm   X                    
31.1   Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002   X                    
31.2   Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002   X                    
32.1   Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002       X                
32.2   Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002       X                

97.1

 

Clawback Policy

         

10-K

 

5/31/2024

 

 97.1

 

8/15/2024

99.1

 

Office Lease Agreement, dated October 12, 2024, between New Lion Enterprises LLC and AXIL Brands, Inc.

         

10-Q

 

11/30/2024

 

99.1

 

1/8/2025

101

 

The following consolidated financial statements from the Annual Report on Form 10-K for the fiscal year ended May 31, 2026 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Changes in Stockholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) the Notes to Consolidated Financial Statements

 

X

                   

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

X

                   

 

*

Management compensatory plan or arrangement.

 

+

The schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K and the Company agrees to furnish to the SEC a copy of any omitted schedules or exhibits upon request.

 

  -36- 

 

Table of Contents

 

ITEM 16. Form 10-K Summary

 

None.

 

  -37- 

 

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

AXIL BRANDS, INC.

     

Date: August 18, 2026

BY:  

/s/ Jeff Toghraie

   

Jeff Toghraie

   

Chief Executive Officer and Chairman of the Board of Directors (principal executive officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

Title

Date

     

/s/ Jeff Toghraie

Chief Executive Officer and Chairman of the Board of Directors (principal executive officer)

August 18, 2026

Jeff Toghraie

   
     

/s/ Jeff Brown

Chief Financial Officer, Chief Operating Officer and Director (principal accounting officer and principal financial officer)

August 18, 2026

Jeff Brown

   
     

/s/ Thomas Penna

Director

August 18, 2026

Thomas Penna

   
     

/s/ Nancy Hundt

Director

August 18, 2026

Nancy Hundt

   
     

/s/ Manu Ohri

Director

August 18, 2026

Manu Ohri

   

 

  -38-